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1. ABSTRACT 
 
Polychlorinated dibenzo-p-dioxins, dibenzofurans (PCDD/Fs) and polychlorinated 
biphenyls (PCBs) are widespread environmental contaminants. They enter the human 
body mainly with food and because of lipophilic character they accumulate in fatty tissues. 
Knowledge about the intake and body burden of PCDD/Fs and PCBs in a population helps 
to focus efforts to diminish population exposure to these compounds.  
This study aimed to interpret the results from a recent biomonitoring study of 
PCDD/Fs and PCBs in breast milk of Italian non-occupationally exposed mothers by a 
PBPK model of mother and infant.  Measurements included detection of 2,3,7,8 
substituted polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and 
polychlorinated biphenyls and estimation of the dietary intake of these pollutants by 
lactating infants. The modelling part was focused on one PCB congener – PCB 153. Here, 
reverse dosimetry was performed to estimate mother external dose, and forward dosimetry 
to predict tissue concentrations in mother and infant daily intake.   
The modeling outcomes provided an historical perspective on the changing exposure of 
the Italian population to PCB-153. They realistically reflect the evolution of daily intake 
during the mother’s life, and evolution of blood contamination. At the same time it was 
proved that breast milk is good biomarker of historical exposure and in combination with 
PBPK modeling can be used to characterize prospectively and retrospectively, internal and 
external exposures. So far, this is the first study which reconstructed the dynamic 
exposure for specific population. Results of this work can dramatically change the way to 
perform modeling for substances such us POPs, similar trends to PCBs is observed for 
PCDD/Fs , DDT, HCB etc.  
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2. INTRODUCTION 
 
During life humans are exposed to the mixtures of different toxic chemicals like 
persistent organic pollutants such as: PCDDsFs PCBs, PBDE, PBBs etc. They enter the 
human body mainly with food and because of lipophilic character accumulate in fatty 
tissues. Dioxins and PCBs are than eliminated from the body by metabolic degradation, 
which is minimal for most congeners, and by excretion which is slow and primarily in 
faeces. However they may also concentrate in human milk, which is considered an 
important route of excretion and a primary source of intake for newborns. Pregnant and 
nursing woman transfer PCBs and dioxins to their babies trans-placentally and by breast-
feeding (respectively prenatal and postnatal exposure), the latter being considered the 
most important source (Jacobson et al., 1984). They are in fact very efficient absorbed in 
the digestive tract of infants to the extent of about 95% of the amount ingested (Dahl et al., 
1995; Abraham et al., 1994). 
Breast milk therefore is widely used in human biomonitorig studies to assess exposure of 
mothers and infants to environmental chemicals (WHO 1989 and 1996). Biomonitoring of 
human tissues provides the evidence of human internal exposure, however to evaluate or 
bound potentially related health risks additional information about external exposure are 
needed. Therefore human biomonitoring is frequently and effectively combined with 
physiologically based pharmacokinetic (PBPK) models which describe the relationship 
between external and internal exposures. 
The aim of PBPK modelling is to describe the physical and physiological processes that 
are involved in the uptake, distribution, and elimination of a compound in an organism in 
great detail. The combination of PBPK modelling and human biomonitoring results in a 
powerful tool for the health risk assessment at individual or population level. Application of 
PBPK models are needed to build hypothesis about possible relationships between 
exposure, dose and disease, and to monitor trends in environmental quality.  Studies like 
this one show that PBPK models are broadly applicable as a tool for relating dose 
biomarker to measures of individual and population exposure and health risk. Moreover 
application of PBPK model gives the possibility to better relate biomarkers to specific 
source and scenario of exposure.  
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This study aimed to interpret results from a recent biomonitoring study of PCDD/Fs 
and PCBs in breast milk of Italian non-occupationally exposed population by a PBPk 
model of mother and infant. The modelling part focuses on one PCB congener – PCB 153. 
There are several reasons why PCB-153 has been selected to carry out computer 
simulations. First of all PCB-153 occurs in human milk at the highest concentration, 
therefore its amount is usually measured precisely.  This congener is suggested as a 
valuable indicator for total amount of PCBs in the food of animal origin (i.e. fish) (Atuma et 
al 1996). Moreover concentration in human serum seems good marker of exposure to 
PCBs via food intake (Axmon et al 2006, Jonsson et al 2005), occupational exposure to 
PCBs during sealant removal operations (Wingfors et al 2006), or exposure of the 
population living in urban zones (Covaci et al 2002). Its presence in breast milk was found 
to be a biomarker of the total sum of TEQ PCDDs/Fs and TEQ DL-PCB (Glynn et al 2001). 
Moreover serum level of PB153 was inversely correlated with free testosterone levels, and 
high level of PCBs – with reduced sperm mobility (Rich Hoff et al 2003, Bush et al 1986). 
In woman positive association between PCBs and increasing menstrual cycle length was 
observed by Copper (Cooper et al 2005). PCBs 138, 153 and 180 were associated with 
increasing risk of asthma (Van Den Heuvel et al 2002). Some authors found a strong 
correlation between maternal blood level of PCB-153, 180 and 138 and endometriosis 
occurrence in Italian woman (Porpora et al 2006, De Filip et al 2004) 
In this study we applied PBPK model for forward and reverse dosimetry in mother and 
infant based on results from biomonitoring of breast milk. Reverse dosimetry was 
performed in order to reconstruct the dietary intake over the mother’s life, taking into 
consideration decreasing tendency in PCBs occurrence in environment. Forward 
dosimetry focused on prediction of mother blood concentration, and infant daily intake.  
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3. CHARACTERISTIC OF PCDD/Fs AND PCBs 
 
3.1 PCDD/Fs. Physical and chemical properties 
 
Term “Dioxins” is a common name of family of organic compounds which consists of 
210 congeners. This group can be divided into two subgroups: PCDDs (polychlorinated 
dibenzo-p-dioxins) and PCDFs (polychlorinated dibenzofurans).  PCDDs and PCDFs are 
almost planar tricyclic aromatic compounds formed by two benzene rings connected by 
two oxygen atoms in PCDDs and one oxygen atom in PCDFs (See Figure 1). The 
hydrogen atoms may be replaced by up to eight chlorine atoms what gives 75 PCDDs and 
135 PCDFs congeners. Above mentioned compounds showed similar chemical properties. 
          
Figure 1. Structures of PCDDs and PCDFs (1-9 indicate the possible positions of the chlorine atoms) 
 
These compounds are highly fat soluble, they have high melting points and low 
vapor pressures and are stable to acids and bases; these characteristics make them very 
persistent in the environment. They bioaccumulate through the food chain. Table below 
shows several chemical properties of PCDDs and PCDDFs 
 
Aberg et al 2008 Kadowaki et al 2000 Aberg 2008 
 
SW, PoL PoL Kp Log10 KOA Log10 KAW 
2378-TCDD 1.59E−5 -3.93 -3.28 -3.32 9.89 -2.91 
12378-PeCDD 8.62E−5 -5.37 -3.83 -2.17 10.32 -3.24 
123478-HeCDD 1.55E−5 -5.84 -4.43 -1.23 10.88 -3.28 
123678-HeCDD 
 
  
   
123789-HeCDD 
 
  
   
1234678-HpCDD 1.93E−5 -6.75 -5.05 -0.595 11.42 -3.55 
OCDD 2.93E−6 -6.02 -5.64 -0.567 12.05 4.37 
2378-TCDF 1.35E−4 -3.7 -3.14 -2.4 10.28 -3.17 
12378-PeCDF 
      
23478-PeCDF 5.25E−5 -4.76 -3.76 -2.26  -3.28 
123478-HeCDF 3.16E−6 -5.51 -4.22 -1.91 10.77 -3.29 
123678-HeCDF 
 -5.44 -4.24 -1.91   
123789-HeCDF 
 
  
   
234678-HeCDF 
 
  
   
1234678-HpCDF 1.74E−6 -6.24 -4.77 -0.888 10.63 -3.24 
1234789-HpCDF 6.31E−7 6.27 -5.03 0.58 11.43 -3.19 
OCDF 2.29E−7 -7 -5.5 0.444  -3.05 
PCDD                                                                PCDF 
Table 1.     
Several physicochemical 
properties of PCDDs and 
PCDFs 
 
SW - Liquid phase water 
solubility at 20oC [mol/m3]    
 
PoL - Subcooled liquid vapor 
pressures at 25oC [Pa]  
 
Kp - particle–gas partition 
coefficient at 25oC [m3/µg]    
 
KOA - Octanol-air partition 
coefficients  
 
KAW - Dimensionless Henry´s 
law constants 
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It is important to highlight that dioxins are unwanted compounds and often 
unavoidable by-products of industrial processes: production of pesticides, bleaching of 
paper pulp. They appear during incomplete combustion processes: industrial and natural. 
  
3.2 PCBs. Physical and chemical properties 
 
Polychlorinated biphenyls (PCBs) are aromatic compounds formed by substitution 
of hydrogen atoms on the biphenyl molecule with chlorine atoms. The chemical formula 
can be presented as C12H10-nCln, where n is a number of chlorine atoms (See Figure 
below). There are 209 congeners, where 130 occur in commercial products. All congeners 
of PCBs are lipophilic, accumulate in fatty tissues and entrance the food chain. PCBs do 
not crystallize, they turn into solid resins. Polychlorinated biphenyls form vapors heavier 
than air but do not form any explosives mixtures with air. They are chemically very stable 
under normal conditions and non-flammable; they have a very low electrical conductivity 
and high dielectric constant. Because of above mentioned properties they have been 
widely use in industry (hydraulic and heat transfer systems as cooling and insulating fluids. 
Other applications included pigments, dyes, repellents, plasticizers etc. Since 1970 
production of PCBs in USA is prohibited, since 1980 also in Europe. 
 
Figure 2. Structural formula of PCBs 
 
Several chemical and physical properties such as liquid phase water solubility,   octanol–
water partition coefficient, vapour pressures, Henry´s law constants, octanol-air partition 
coefficient and octanol solubility for selected PCBs congeners are presented in the Table 2 
below (Li et al 2002) 
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congener SW, Log10 Kow PL Log 10 Kaw Log KOA Log 10 SoL 
PCB-28 8.85-04 5.66 2.70E-02 1.48 7.85 2.89 
PCB-52 4.78E-04 5.91 1.20E-02 1.39 8.22 2.90 
PCB-101 1.02E-04 6.33 2.46E-03 1.38 8.73 2.72 
PCB-118 6.83E-05 6.69 9.91E-04 1.16 9.36 2.96 
PCB-138 1.87E-05 7.21 5.63E-04 1.47 9.66 3.00 
PCB-153 3.07E-05 6.87 6.06E-04 1.29 9.44 2.83 
PCB-180 1.32E+05 7.16 1.08E-04 0.91 10.16 2.80 
 
Table 2.    Several physicochemical properties of PCDDs and PCDFs [Li et al 2002] SW - Liquid phase water 
solubility at 20oC [mol/m3] Kow - Octanol–Water Partition Coefficient, PL - vapor pressures  [Pa], KAW - 
Dimensionless Henry´s law constants,  KOA - octanol-air partition coefficients, SOL  Octanol Solubility in 
[mol/m3] 
 
 
PCBs congeners can be grouped according to their degree of chlorination, 
endocrine disrupting activity or pattern of enzyme induction. From the toxicological point of 
view PCBs are divided into 3 groups: non-ortho, mono-ortho and di-ortho substituted 
PCBs. Between them congeners non-ortho and mono-ortho bound to the Ah receptor, 
show toxicological activity comparable to that of dioxins, and that’s why they are called 
”dioxin-like PCBs”.  
Dioxin like PCBs Non dioxin like PCBs 
Non orto PCBs Mono orto PCBs 
Di-orto PCBs 
so called PCBs Indicators 
3,3’,4,4’-TeCB (77) 2,3,3’,4,4’-PeCB (105) 2,4,4' TriCB (28) 
3,4,4’,5-TeCB (81) 2,3,4,4’,5 -PeCB (114) 2,2',5,5'-TeCB (52) 
3,3’,4,4’,5 PeCB (126) 2,3’,4,4’,5-PeCB (118) 2,2',4,5,5'-PeCB (101) 
3,3’,4,4’,5,5’ HxCB (169) 2,3,4,4’,5- PeCB (123) 2,3',4,4',5-PeCB (118) 
 2,3,3’,4,4’,5 -HxCB (156) 2,2',3,4,4',5'-HxCB (138) 
 2,3,3’,4,4’,5’-HxCB (157) 2,2',4,4',5,5'-HxCB (153) 
 2,3’,4,4’,5,5’-HxCB (167) 2,2’,3,3’,4,4’,5-HpCB (170) 
 2,3,3’,4,4’,5,5’-HpCB (189) 2,2’,3,4,4’,5,5’-HpCB (180) 
Table 3. PCBs nomenclature : IUPAC names and Ballschmiter & Zell (1980) name system in parenthesis  
 
Non dioxin like PCBs create a group of congeners called PCBs indicators due to the fact 
that occur at higher concentration in environment than other congeners and account for 
50-80% of total amount of PCBs (Noren et al 2000). Instead of laborious and expensive 
analysis of all 2,3,7,8 substituted PCBs congeners it is possible to estimate the total 
amount of PCBs based on the measurement of only the PCBs indicators.  
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3.3 Toxicological characteristic of PCDD/Fs and PCBs 
 
It is very difficult to assess a human health effects separately for PCBs, PCDFs, 
PCDDs because those compound usually occur as a mixtures of many congeners. 17 
dioxins and dioxin like PCB congeners have been shown to be toxic at low levels, they 
bind to the same dioxin-receptor but with the different intensities and with the different 
toxicity. This different toxicity is expressed by a TEF (toxicological equivalency factor), 
which express the toxicity of the various congeners. Congeners substituted in the 2,3,7,8 
position are of special importance and for the most toxic 2,3,7,8 tetrachlorodibenzeno-p-
dioxin (2,3,7,8 TCDD)  TEF is of 1 (See Figure 3 below) 
 
Figure 3. Chemical formula of 2,3,7,8 tetrachlorodibenzeno-p-dioxin (2,3,7,8 TCDD)   
 
Usually the toxicity of a mixtures of dioxins is expressed as a TEQ value (toxic 
equivalents). To determine the TEQ of a mixture, the amount of each of the toxic members 
of the family is multiplied by its TEF, and the TEQs are summered (See Table 4) 
TEQ = Σ (mi  x TEFi)  
 
Congener WHO-TEF 1998 
WHO – TEF 
2005 Congener 
WHO – TEF 
1998 
WHO-TEF 
2005 
2,3,7,8-TCDD 1 1 Mono orto PCBs   
1.2.3.7.8-PeCDD 1 1 2,3,3’,4,4’-PeCB (105) 0.0001 0.00003 
2,3,4,4’,5 -PeCB (114) 0.0005 0.00003 
2,3’,4,4’,5-PeCB (118) 0.0001 0.00003 
1,2,3,4,7,8- HxCDD 
1,2,3,7,8,9- HxCDD 
1,2,3,6,7,8- HxCDD 
0.1 0.1 
2,3,4,4’,5- PeCB (123) 0.0001 0.00003 
1,2,3,4,6,7,8- HpCDD 0.01 0.01 2,3,3’,4,4’,5 -HxCB (156) 0.0005 0.00003 
OCDD 0.0001 0.0003 2,3,3’,4,4’,5’-HxCB (157) 0.0005 0.00003 
2,3,7,8- TCDF 0.1 0.1 2,3’,4,4’,5,5’-HxCB (167) 0.00001 0.00003 
2,3,3’,4,4’,5,5’-HpCB (189) 0.0001 0.00003 2,3,4,7,8- PeCDF 
1,2,3,7,8- PeCDF 
0.5 
0.05 
0.3 
0.03 Non orto PCBs   
3,3’,4,4’-TCB (77) 0.0001 0.0001 
3,4,4’,5-TCB (81) 0.0001 0.0003 
3,3’,4,4’,5 PeCB (126) 0.1 0.1 
1,2,3,4,7,8- HxCDF 
1,2,3,6,7,8- HxCDF 
1,2,3,7,8,9- HxCDF 
2,3,4,6,7,8- HxCDF 
0.1 0.1 
3,3’,4,4’,5,5’ HxCB (169) 0.01 0.03 
1,2,3,4,6,7,8- HpCDF 
1,2,3,4,7,8,9- HpCDF 0.01 0.01    
OCDF 0.0001 0.0003    
 
Table 4. Comparison of TEF factor. Van den Berg et al 2006  
 
A number of human epidemiologic and animal experimental studies have 
established an association between  dioxins and effects on  endocrine systems and 
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immune system  (Pluim HJ et al 1993, Safe S et al 1990). Dioxins can block the action of 
estrogens under certain conditions, can lower the levels of androgens and affect the 
amount of thyroid hormones in the body (Safe S et al 1991). They increase serum 
triglycerides and cholesterol, well-established risk factors for cardiovascular disease  
(Martin JV et al 1984, Pazderova-Vejlupkova J et al 1981). TCDD is the most toxic among 
all dioxins congeners and classified as a group 1 carcinogen (IARC 1997), during  infancy 
and prepuberty has permanent effect on semen quality and causes reduction of estradiol 
and growth of follicle-stimulating hormone (Mocarelli et al 2008). Dioxins showed also a 
significant negative relationship to the frequency of delta SCEs (sister chromatid 
exchanges), seemed to elicit some genotoxic / clastrogenic effects on infants postnatal of 
around 10 months (Nagayama et al 2003) and was associated with higher prevalence of 
coughing, chest congestion, and phlegm . (Weisglas – Kuperus et al 2000 ) 
Mothers poisoned with rice oil (Yu-Cheng disease) reported lower birth weight, 
hyperpigmentation, conjunctivitis, nail changes, and natal teeth in their offspring and delay 
in developmental milestones (Rogan et al 1988). Exposed Yu- Cheng children at school 
age showed lower IQs (Chen et al 1992), behavioral effects (Chen et al 2994) and 
physically and mentally delayed (Guo et al 1994,  Chen et al 1992) .Moreover effects on 
the external genitalia of boys at puberty who were born to exposed mothers had been also 
observed Guo YL, et al 1993;  Jacobson and Jacobson 1990). Increased maternal 
consumption of fish contaminated with dioxins and furans in Sweden was associated with 
lower infant birth weights (Rylander et al. 2000) and higher proportion of spontanius 
abortion was observed in mothers living ion contaminated zone next to chemical plant in 
Chapayevsk, Russia (Revich et al. 2001) 
PCBs are carcinogens and cancer promoter and chronic exposure results in 
chromosomal aberrations (Silberhorn et al 1990). A number of occupational studies have 
reported increased numbers of various PCB associated cancers—liver, gall bladder, biliary 
tract, leukaemia, gastrointestinal, skin (especially malignant melanoma), lymphoma, lung, 
pancreatic (ATSDR,2000; Longnecker et al 2003; Sinks et al 1992; Moysich et al 2002; 
Demers et al 2002; Yassi et al 1994). An exposure to PCBs can suppress the antibody 
and cellular immune response (Lu et al 1985, Weisglas-Kuperus et al 1995) and what is 
the consequence increased susceptibility to infections and to cancer.  
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A wide variety of endocrine systems are affected by PCBs i.e estrogens and 
androgen system (Golden et al 1998), retinoid system corticosteroid system, thyroid 
hormone system (Koopman-Esseboom  et al 1994, Wang et al 2005) also at background 
levels (Schell et al 2005). Serum level of PB153 was inversely correlated with free 
testosterone levels, and high level of PCBs – with reduced sperm mobility (Richthoff et al 
2003, Bush et al 1986). In woman positive association between PCBs and increasing 
menstrual cycle length was observed  by Copper (Cooper et al 2005). PCBs 138, 153 and 
180 were associated with increasing risk of asthma (Van Den Heuvel et al 2002). Many 
authors found a strong correlations between exposure to PCBs (mostly level in serum) 
and: plasma triglyceride levels and /or lipids level (Mochizuki 1998, 2004; Boll et al 1998; 
Bell et al 1994; Chase et al 1982; Moysich  et al 2002; Tokunaga  et al 2003), higher 
serum cholesterol and blood pressure (Kreiss et al 1981).  Notable serum lipid levels and 
hypertensions are risk factors for cardiovascular diseases. (Wilsgaard et al 2001). 
In Dutch cohort study conducted by Weisglas-Kuperus et al.1995, 2000; 2004, higher PCB 
levels were associated with a higher incidence of recurrent middle-ear infections (elevated 
3-fold) and of chicken pox (elevated 7.6-fold) in 42 months old children, but a lower 
prevalence of asthma. The children with higher PCB levels had more coughing, chest 
congestion, and phlegm. The same children several years later were found to have a 
persistently higher prevalence of ear infections (Weisglas-Kuperus et al 2004). In utero 
exposure to PCBs has been linked to adverse effects on intellectual function in infants and 
young children like irreversible decrement of IQ. Results of  pre- and postnatal exposure 
study of Jacobson and Jacobson 1996,  in children born to women who during pregnancy 
had eaten fish contaminated with PCBs showed a significant reduction in full scale IQ and 
poorer performance on reading mastery. Investigations on background levels of PCBs in 
breast milk (Rogan et al 1986) and cord blood (Walkowiak et al 2001) showed negative 
effect on both mental and motor development in children at all ages and  alteration of the 
nervous system performance of children. Also exposure to PCBs during the adulthood 
results with negative effects on health. Study on memory function between 49- to 86-year-
old adults (Schantz et al 2001) exposed to contaminated Great Lakes fish clearly showed 
decrement of IQ and reduction of memory.  
In utero exposure to environmental levels of PCBs in negatively associated with 
birth weight and postnatal growth until 3 mo of age (Koopman-Esseboom  et al 1996).  
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Prenatal PCBs exposure showed correlation with lower growth rate (Patandin et al 1998), 
lower psychomotor scores at 3 months age (Koopman-Esseboom  et al 1996) 6 and 12 
months (Gladen et al 1988), poorer neurological conditions at birth (Huisman et al 1995), 
hypotonicity and hyporeflexia in newborns (Rogan et al 1986),  poorer short-term memory 
functions at 4 years (Jacobson et al 1990). Infants exposed to higher toxic equivalence 
levels (PCBs, PCDDs and PCDFs) showed lower plasma free thyroxine and total thyroxine 
levels in the 2nd week after birth (Koopman-Esseboom  et al 1994). 
 
4. HUMAN EXPOSURE TO PCDD/Fs AND PCBs 
 
 Human environmental exposure to dioxins and PCBs occurs on several ways: via 
inhalation, food consumption, dermal absorption and ingestion of contaminated soil. 
Taking into consideration the chemical and physical properties of dioxins and PCBs is 
easy to deduce that food will be the most important path. Indeed many scientific studies 
focused on dioxins and PCBs exposure assessment via food (Llobet et al 2003, Fattore et 
al 2006, Fattore et al 2008) and proved this hypothesis.  Figure 4 below presents 
schematic human exposure to persistent organic pollutants. 
 
Figure 4 Human exposure to persistent organic pollutants 
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Additional exposure may occur in accidents or because of occupational contact with 
these pollutants. Several incidents in which populations were exposed to high levels of 
PCDDs PCBs are: an industrial explosion that occurred during the production of 2,4,5-TCP 
at the ICMESA plant in Seveso, Italy in 1976; and an incident with 2,3,7,8-TCDD-
contaminated waste oil in Missouri in 1971/72. High exposure may be caused by 
accidentally contaminated food like contaminated rice oil in Yusho in Japan (1968) and Yu-
Cheng in Taiwan.  
However for general population the accidental and occupational exposure is minimal, 
much more important is impact from consumed food. 90% of daily dioxins and PCBs 
intake arrives from food consumption, mainly fish, egg, oil, meat, milk and its products (De 
Filip et al 2004, Parzefall 2002). Therefore a number of authorities have assessed or re-
assessed risks of PCDD/Fs and DL-PCBs. WHO re-evaluated the risk assessment of 
PCDD/Fs and related compounds  in 1998. Based on investigations such as: with 
laboratory animal results on decreased sperm count, immune suppression, increased 
genital malformations, neurobehavioral effects, and endometriosis, the consensus meeting 
ultimately suggested a range of TDI intakes for humans (1-4 pg TEq/kg body weight (bw)) 
(van Leeuwen and Younes 2002). Than The Scientific Committee on Food (EU SCF) of 
the European Commission assessed a TWI of 14 pg WHO-TEq/kg bw for PCDD/Fs and 
for DL- PCBs (European Commission 2001) based on the rodent studies. This guideline is 
in line with the tolerable monthly intake (70 pg WHO-TEq/kg bw) established by the Joint 
FAO/WHO Expert Committee on Food Additives, JECFA (WHO/FAO 2001).  
In November 2000 the Scientific Committee on Food of the European Commission 
published an ‘Opinion of the SCF on the Risk Assessment of Dioxins and Dioxin-like PCBs 
in Food’ (SCF, 2000). On the basis of this extensive review the committee recommended a 
temporary tolerable intake on a weekly basis (t-TWI), because of the long half-lives of 
dioxins in humans (7 years or more) with a value 7 pg WHO-TEQ/kg bw per week. Few 
months later on the basis of further findings this limit was changed to 14 pg/kg bw per 
week.  
Recent guidelines on tolerable intakes (as pg WHO-TEq / kg bw) of PCDD/Fs and PCBs 
according to risk assessments by different organizations are presented below: 
 
• WHO (2000): TDI 1–4 pg WHO TEQ/kg bw per day 
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• SCF (2000): t-TWI 7 pg WHO TEQ/kg bw per week 
• SCF (2001): TWI 14 pg WHO TEQ/kg bw per week 
• JECFA (2001): PTMI 70 pg WHO TEQ/kg bw per month 
 
4.1 CONTAMINATION OF FOOD. 
 
As mentioned above, more than 90% of daily dioxins and PCBs intake comes from food 
consumption. Between different kinds of foodstuffs the most contaminated are fishes, 
meats and animal origin products. Contamination of food is primarily caused by deposition 
of emissions of various sources (like waste incineration, production of chemicals etc.) and 
subsequent accumulation in the food chain. 
Table 5 below shows concentrations of PCDDs, PCDFs, and PCBs in foods in 
various European countries. Data for most of European conuntries are available in 
European Commission Report from 7th June 2000 “Assessment of dietary intake of 
dioxins and related PCBs by the population of EU Member States. However official EU 
Commission data are not available for countries: Austria, Bulgaria, Cyprus, Czech 
Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Luxembourg, Malta, Poland, 
Portugal, Romania, Slovakia, Slovenia, Spain.  
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Food 
category Country 
1990-
1994 
1995-
1999 
1990-
1994 
1995-
1999 
Food 
category Country 
1990-
1994 
1995-
1999 
1990-
1994 
1995-
1999 
DE 1.08 1.16   IT  0.7   
FI 1.55    NL 1.77 0.72   
FR 
 0.46   
Beef 
SV 
 0.98  1.08 
IT 
 2.67         
NL 2 1.08   DE  2.6   
NO 1.97  8.91  FR  3.29   
SV 
 1.03  1.45 IT  2.3   
Eggs 
UK 8.27 1.77 2.36 0.97 NL 5.7    
 
 
    
Liver 
caw 
SV 
 0.95  1.65 
NL 1.51          
SV 
 0.77  0.42 DE 0.62 0.58   Fat and Oil 
UK 1.26 0.26 1.29 0.39 IT  0.92   
BE 2.6 2.06   NL 1.63 0.89   
DE 0.86 0.57   
Poultry 
SV 
 0.77  0.7 
DK 
 0.49         
FI 0.99 0.34  0.23 DE  0.79   
FR 
 0.67   NO 0.91  2.64  
IT 
 0.57   SV  0.73  1.11 
NL 1.56 0.94   
Herring 
UK 
 2.1  6.24 
NO 0.32  1.28        
SV 0.92 0.75  0.43 DE  0.29   
Milk and 
milk 
products 
UK 1.41 1.01 0.91 1.8 IT  0.86   
 
 
    
NO 0.52  1.4  
FI 
 0.02   UK  0.61  2.5 
FR 
 0.02   
Mackerel 
DE 
 0.05   
NL 0.01          
SV 
 0.17  0.11 NO 0.2    
Cereals 
and it 
products 
UK 0.11  0.02  SV  0.13  0.23 
 
 
    
Cod 
UK 
 0.03  0.07 
DE 0.01 0.01         
FI 
 0.02  0.01       
FR 
 0.06         
DE 0.71 0.66         
FI 0.02          
Fruits and 
vegetables 
 
    
 
 
    
Table 5.  National average concentration of dioxins and PCBs in foods. (SCOOP 2000) 
 
Data confirm that fish, egg, and milk are the main (Domingo et al 1999, SCOOP 
2000). source of dioxins and PCBs Concentration of dioxins in eggs are in the range 0.5-
2.7 pg I-TEQ/ g fat. This level depends on type of breeding. In oils and fats dioxins and 
PCBs were ca 1 pg I-TEQ/ g fat. Concentration was relatively higher in oils of animal 
origin, professionally at fish oil. In fact high-trophic-level marine species are known to 
contain high concentration of POPs ( e.g PCBs, dioxins, PBDEs) (Fangstrom et al 2005, 
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Dam et al 2000, Lindstrom et al 1999). Average concentration in milk and milk products 
were in the range 0.3-2.1 pg I-TEQ/ g fat for dioxins and 0.2-1.8 pg I-TEQ/ g fat for PCBs. 
Cereals, fruit and vegetables had lower concentration near to the limit of determination 
(0.05-0.1 pg I-TEQ/ g of product). Concentration in meet and meets products were in 
range 0.6-1.0 pg I-TEQ/ g fat. Salmon, eel, herring were the fish with the highest level of 
contamination. Comparing data between farmed fishes, and wild fishes, the first one 
showed lower contamination. Fishes from Baltic Sea presented relatively higher level of 
dioxins and PCBs in comparison with the same species from other regions.  
More recent data (2003-2004) are available for PCBs in salmon, butter and 
cabbage samples from Italy, Belgium, Portugal and Spain. Data with average TEQ pg/g fat 
are summarized in Table below. Data are not available for dioxins. The comparison with 
concentrations reported by European Commission 2000 showed that levels are slightly 
lower.  
 
 
Italy Belgium Portugal Spain 
Salmon [TEQ pg/g fat] 3.2 0.9 1.2 2.7 
Butter [TEQ pg/g fat] 0.16 0.13 0.04 0.12 
Cabbage [TEQ pg/g ww] 0.0006 0.00004 0.00006 0.0009 
 
Table 6. WHO-TEQs equivalents for dioxin like PCBs in salmon, butter and cabbage (Zuccato et al 2008) 
 
There is no comprehensive report at the international level about dioxins and PCBs 
levels between new members of European Union neither complex report at European level 
from 2004-2008. There are individual information’s about level of those contaminants in 
foodstuff coming from single country.  
Research from between 1996-2008 determined the concentrations of PCDD/PCDFs in a 
foodstuffs samples consumed in northern regions of Spain (Llobet et al 2003, Bocio et al 
2005, Domingo et al 1999, Martin-Cid et al 2008). With respect to the PCDD/Fs WHO-TEQ 
values, practically all food groups showed very notable reductions in comparison with the 
WHO-TEQ values from 1996. Data for different food stuffs are presented in Table 7 are 
presented below. 
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pg WHO-TEQ 
PCDD/Fs Vegetables 
Pulses 
cereals 
Fruits & 
Vegetables 
Fish and 
shelfish Meat Eggs 
Milk and 
products 
Fats & 
oils 
1996 1.61 0.75 0.49 6.23 1.27 1.25 1.35 0.79 
2000 0.11 0.07 0.06 5.57 0.47 0.58 0.8 0.18 
2002 0.006 0.011 0.008 0.27 0.03 0.037 0.019 0.238 
2006 0.004 0.015 0.003 0.086 0.012 0.134 0.003 0.147 
 
Table 7. PCDD/PCDF concentrations in food samples collected in different locations from Tarragona Region 
(Catalonia, Spain) Llobet et al 2003, Bocio et al 2005, Domingo et al 1999, Martin-Cid et al 2008 
 
 
Monitoring of PCDD/Fs and DL-PCBs (PCB-77, PCB-88, PCB-126, PCB-169) in Greece 
showed similar effects (Papadopoulos et al 2004), samples from 2002 had dioxin content 
far below the EC Regulation (2375/2001/EC) limits. It can be notice also that food of 
animal origin contain higher levels of contaminants than food of plan origin. (See Table 8 
below) 
 
Mean 
(range) 
Butter 
(n = 5) 
Yoghurt 
(n = 2) 
Cow milk 
(n = 3) 
Beef 
(n = 3) 
Pork 
(n = 4) 
Poultry 
(n = 3) 
Fish—
aqua 
culture 
(n = 7) 
Eggs 
(n = 6) 
Olive oil 
(n = 5) 
Fruit ** 
(n=5) 
Vegetable** 
(n=4) 
ΣPCDD/F 
[pg/g 
fat]** 
9.93 
(7.10–14.64) 
5.56 
(3.90–7.23) 
3.43 
(3.08–3.72) 
10.94  
(7.64–14.34) 
23.29 
(4.37-37.08) 
5.55 
(2.91–9.38) 
13.19 
(8.76-17.9) 
4.06 
(3.65–4.82) 
10.27 
(1.90-38.49) 
3.3 
(2.64-4.43) 
3.55 
(2.95-4.33) 
ΣTEQ 
PCDD/F 
0.79 
(0.29–1.33) 
0.44 
(0.38–0.51) 
0.39 
(0.34–0.47) 
0.55 
(0.52–0.59) 
0.39 
(0.32–0.42) 
0.30 
(0.18–0.40) 
0.47 
(0.22–1.12) 
0.37 
(0.26–0.45) 
0.30 
(0.23–0.36) 
0.47 
(0.37-0.54) 
0.43 
(0.37-0.48) 
Σ PCB * 
[pg/g 
fat]** 
5.16 
(1.23–9.30) 
6.07 
(3.25–8.90) 
3.04 
(1.64–5.30) 
16.37 
(13.06-20.46) 
169.4 
(67.35-347.7) 
8.22 
(5.78–13.1) 
394.03 
(222–749) 
12.24 
(7.10–
24.32) 
2.40 
(2.02–4.83) 
0.36 
(0.27-0.40) 
0.36 
(0.36-0.37) 
ΣTEQ-
PCB* 
0.32 
(0.01–0.66) 
0.41 
(0.14–0.67) 
0.18 
(0.07–0.34) 
0.41 
(0.01–0.69) 
0.69  
(0.27–1.22) 
0.06 
(0.04–0.11) 
1.19 
(0.56–2.90) 
0.13 
(0.06–0.33) 
0.04 
(0.01–0.09) 
0.01 
(0.01-0.01) 
0.01 
(0.01-0.01) 
 
Table 8. Average results of PCDD/Fs and PCBs (Papadopoulos et al 2004) *ΣPCB=PCB-77+PCB-
88+PCB-126+PCB-169,  
 **For Fruits and Vegetables ΣPCDD/F and Σ PCB expressed in pg/g  wet weight 
 
Cited data demonstrated significant time reduction of dioxins and PCBs 
contamination in foodstuff. Less contaminated food has an influence on human exposure 
to dioxins and PCBs. In Netherlands a decrease of 50 percent of the intake of I-TEQ/kg 
bw/day was observed, in United Kingdom research data showed the exposure has also 
fallen around 45%. (SCOOP 2000). Investigations of German food have shown exposure 
approximately 50% lower than 10 years ago (SCOOP 2000). In general every year the 
average dietary exposure to dioxins within EU Members is decreasing around 9%-12%. 
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(SCOOP 2000). It is a result of changing model of food consumption and decreasing 
concentration of dioxins in food and feed. 
 
4.2  Reconstruction of historical food contamination and historical 
dietary intake of  PCB-153.  
 
Consumption of food is considered as the major source of non-occupational human 
exposure to PCBs. More than 90% of total daily intake of these contaminants derives from 
the food. Here is presented an assessment of dietary exposure to PCB-153, one of the 
PCB indicator which occur at higher concentrations respect to other contaminant of 
interest. Estimation is obtained by combining data from National Italian Food Consumption 
Survey (INRAN-SCAI) (Leclerq et al 2008) with literature data about concentrations and 
profiles of PCB in Italian foodstuffs. (Fattore et al 2008) 
Details about foods consumption were obtained from cross sectional study of 
Leclerq et al 2008 conducted in Italian territory between 2005-2006 which is the key 
reference for Italian food consumption and is utilized for risk analysis or assessment of 
nutrients intakes. In this study subjects were divided into several groups: infants, children, 
teenagers, adults and elderly. Last three groups were divided into male and female 
subgroups. Classification of food was based on classification developed by European 
Food Safety Authority (EFSA). Fat content of each food item was consulted with Italian 
Tables of Food Composition developed by INRAN and available on line: 
http://www.inran.it/646/tabelle_di_composizione_degli_alimenti.html. All data are 
presented in Table 9 below: 
 
Consumption g/day 
Fat content 
(%) 
Infant 
(0-3) 
child 
(3-10) 
teenage 
(10-18) 
adult 
(18-65) 
Elderly 
(65-86) 
Cereals and its products - 125 238 265.3 232.3 228.3 
fruit and vegetables - 242.4 350 447.6 511.1 560.2 
eggs 8.7 13.4 25.7 26.1 25.7 26.5 
fatt and oils 91.825 15.5 33.2 39.1 38.8 34.4 
fish and fishery products 10.51 47.9 58.9 68 65.4 56.2 
meat and meat products 9.24 60 100 107.4 98.4 90.3 
milk and milk products 17.15 397 259 218 194.5 201.5 
Table 9 Food consumption in Italy and fat content (Leclerq et al 2008, INRAN on-line Data base) 
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Concentrations of PCB-153 in foods were obtained from Italian study of Fattore et al 
2008, where values were expressed in ng/g of fat or ng/g of fresh weight for following food 
groups: cereals and its products, fruit and vegetables, fats and oils, fish and fishery 
products, meat and meat products, milk and dairy products.  
Daily intake of PCB-153 was calculated as multiplication of food consumption rate, fat 
concentration in each food item and contamination with PCB-153 (see equation below). 
 
Intake = Imeat + Ifish + Icereal + Ivegetables + Imilk + Ioil + Ieggs 
Imeat = Mmeat [g/day] * FC [%] * CPCB-153 [ng/f of fat]  
Where: 
I    – Intake  
M    – Consumption of meat and meat products in [g/day] 
FC   – fraction of fat in meat (%) 
CPCB-153  – concentration of PCB-153 in meat and meat  products [ng/g of fat] 
 
The aim of this exposure assessment was to reconstruct the most realistic history of PCB 
intake for woman born in around 1970-1980, putting special attention on changing level of 
contaminants since the mid seventies up to 2009/2010.  
To have clear idea on distribution of PCBs in environment in the past several studies and 
documents were used: “Italian emission Inventory 1990-2007” (Ispra 2009), “Towards a 
global historical emission inventory for selected PCB congeners – a mass balance 
approach. Parts: I, II, III” (Breivik et al 2002a, 2002b, 2007), and other single studies: 
Breivik et al 2004, 2006, 2010, Van Der Gon et al 2007, Wania et al 1999, Norstrom et al 
2009, Pacyna et al 2003.  
Data on PCB-153 emission for Italy (1943-2000) were obtained from the study of Breivik et 
al 2002a, 2002b, 2007, and were downloaded from the website as the excel files 
http://www.nilu.no/projects/globalpcb/globalpcb2.htm. Data since 2000 to 2007 were 
implemented with “Italian emission Inventory 1990-2007” (Ispra 2009).  
Results of Breivik’s study are presented as three type of emission scenarios High, Mid and 
Low. High and Low scenarios were created in order to adjust the default (mid) estimates. 
This adjustment avoids the over- or underestimation which may appear due to uncertainty 
which affects several model parameters and due to limited or lack of empirical evidence 
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(Breivik et al 2002a, b). According to Breivik’s methodology, three scenarios of air 
contamination with PCB-153 were created, and than three scenarios of food 
contamination. Food contamination data were used to calculate daily intake for each year 
from 1940 to 2009. Information about PCB153 concentration in the air in Italy were 
obtained from analytical measurement in 2008 (data not published). Concentration in the 
food in the past was calculated as the simple ratio based on literature data of Fattore et al 
2008 and Zuccato et al 1999. The results of estimation for food contamination and dietary 
intake are presents in Figures 5 A, B below. Figure 5B shows an example of historical 
daily intake for woman born in 1980. As presented, the difference between three intake 
scenarios is of 102. All three estimations keep decreasing tendency, arriving to plateau 
around the mid 90ties. This is a very general estimation, based on simple assumption that 
certain concentration of PCB-153 results in certain concentration of PCB in the food. Even 
if is simple, this estimation is sensible enough to reflect dynamic change in environmental 
pollution. The shape of intake curves show strong decreasing trend in early years of life, 
which is the result of drop in PCB emission. Observed plateau in adulthood is due to the 
constant dietary habits and lower food contamination. This estimation was introduced to 
the model in order to it compare with reverse dosimetry results.  
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Figure 5A. Estimation of food contamination with PCB-153 in Italy since 1940-2010 
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Figure 5B. Estimation of daily intake of PCB-153 in Italy since 1980-2010. An example for woman born in 1980. 
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5. CONTAMINATION OF HUMAN MILK. INFANT EXPOSURE 
 
5.1 PCDD/F and DL-PCB LEVELS IN HUMAN MILK: HISTORICAL STUDIES 
 
Several surveys on dioxins and PCBs in human milk have been made in the past. 
For instance the report prepared for European Commission DG Environment and the UK 
Department of the Environmental Transport and the Regions in 1999 (Buckley-Golder, 
1999) reviews results from samplings carried out in 1988-1993. Several EU member states 
took part in this study, including Austria, Belgium, Denmark, Finland, France, Germany, 
Italy, Netherlands, Spain, Sweden and UK. During the eight year period, milk samples 
from mothers living in industrial, urban and rural zones of these countries were collected 
and analyzed for their dioxin content. Table 9 shows the average concentrations of PCDDs 
and PCDFs in human milk measured in this survey. Between 1988 and 1993, 
concentrations decreased by about 35% (8.3% per year) with lower mean concentrations 
and  a slightly smaller decrease in rural than in industrial areas. 
 
 Average concentration  
pg I-TEQ/g fat 1988 
Average concentration  
pg I-TEQ/g fat 1993 
Rural area 28.2 17.7 
Urban area 29.5 19.2 
Industrial area 35.9 24 
 
Table 9. Mean PCCD and PCDF concentrations in human breast milk. (pg I-TEQ/g fat) (Buckley-Golder, 
1999). 
 
A similar study was done by the World Health Organization (WHO). PCDDs, PCDFs and 
PCBs in human milk were measured in 1987-1988, 1992-1993, and 2001-2003 in 
Australia, Belgium, Brazil, Bulgaria, Croatia, Czech Republic, Egypt, Fiji, Finland, 
Germany, Hong Kong SAR, Hungary, Ireland, Italy, Luxembourg, New Zealand, The 
Netherlands, Norway, Philippines, Romania, Russia, Slovak Republic, Spain, Sweden, 
Ukraine, and United States (WHO 1989 and 1996; Van Leeuwen et al., 2002).  
In the third study period (2001-2003) levels of contaminants in human milk were lower in 
the Southern hemisphere (Fiji, Brazil, Philippines, Australia, New Zealand), eastern 
Europe (Bulgaria, Croatia, Hungary), Ireland and USA, and higher in Western Europe 
(Italy, Spain, Germany, Luxembourg, Belgium, Netherlands) and in Ukraine, where dioxin-
like PCBs were particularly high. In breast milk samples from Egypt PCDD/Fs (median 
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22.3 pg WHO-PCDD/F-TEQ/g fat) contributed a remarkably high proportion to the total 
toxic equivalent (TEQs). The survey identified a decrease in WHO-TEQ PCDD/Fs and 
PCBs in human milk from 1992-1993 to 2000-2003 (Figure 6). Results from this studies 
are summarized in Table 10 
PCDDs/PCDFs 
WHO-TEQ pg/g fat 
PCBs 
WHO-TEQ pg/g fat 
Sum indicator PCBs 
ng/g fat 
PCDDs/PCDFs 
WHO-TEQ pg/g fat 
PCBs 
WHO-TEQ pg/g fat 
Sum indicator PCBs 
ng/g fat Country 
Median Range Median Range Median Range 
Country 
Median Range Median Range Median Range 
Italy 12.66 9.40 – 14.83 16.29 11.02 – 19.33 253 195 – 323 Australia 5.57 5.39 – 5.75 2.89 2.52 – 3.26 30 25 – 36 
Luxembourg 14.97 13.68 – 16.25 13.67 12.98 – 14.36 217 196 – 237 Belgium 16.92 14.78 – 19.07 12.6 11.22 – 14 191 169 – 213 
New Zealand 6.86 6.08 – 7.00 3.92 3.50 – 4.71 37 30 – 41 Brazil 3.92 2.73 – 5.34 1.77 1.30 – 12.28 16 10 – 97 
Norway 7.3 7.16 – 7.43 8.08 6.56 – 9.61 119 106 – 132 Bulgaria 6.14 5.08 – 7.11 4.21 3.74 – 4.70 42 32 – 52 
Philippines 3.94 3.64 – 4.24 2.38 2.22 – 2.54 26 26 – 26 Croatia 6.4 5.99 –6.80 7.17 6.82 – 7.52 135 121 – 150 
Romania 8.86 8.37 – 12.00 8.06 8.05 – 8.11 173 165 – 198 
Czech 
Republic 
7.78 7.44 – 10.73 15.24 14.32 – 28.5 502 496 – 1009 
Russia 9.36 7.16 – 12.93 13.45 12.92 – 22.95 126 84 – 311 Egypt 22.33 14.90 – 51.50 5.48 4.41 – 8.26 106 12 – 140 
Slovak Republic 9.07 7.84 – 9.87 12.6 10.72 – 19.49 443 331 – 621 Fiji 3.34 3.17 – 3.51 1.75 1.70 – 1.80 17 16 – 19 
Spain 11.56 10.24 – 18.68 9.42 6.93 – 17.94 241 162 – 467 Finland 9.44 9.35 – 9.52 5.85 5.66 – 6.03 91 84 – 98 
Sweden 9.58 – 9.71 – 146 – Germany 12.53 11.14 – 12.72 13.67 12.80 – 14.3 220 188 – 238 
The Netherlands 18.27 17.09 – 21.29 11.57 10.90 – 13.08 192 178 – 210 
Hong Kong 
SAR 
8.69 5.80 – 10.09 4.73 2.80 – 6.58 45 16 - 80 
Ukraine 10.04 8.38 – 10.16 19.95 14.10 – 22.00 136 103 – 148 Hungary 6.79 5.26 – 7.46 2.87 2.38 – 4.24 34 29 – 59 
USA 7.18 6.22 – 8.14 4.61 3.69 – 5.52 54 43 – 64 Ireland 7.72 6.19 – 8.82 4.57 2.72 – 5.19 60 41 – 65 
 
Table 10. PCDD/Fs, DL-PCBs and NDL-PCBs (the so called six indicator PCBs) in human milk (Van 
Leeuwen et al., 2002). 
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Figure 6 A-Levels of WHO-TEQ PCDD/Fs in breast milk, B-Levels of WHO-TEQ DL-PCBs in breast milk 
(Van Leeuwen and Malish 2004, WHO second round 1998) 
 
These results will be used in this review as an “historical” reference for the time- and 
geography-related changes in these contaminants in human milk in more recent years. 
However the representativeness of the “national reference levels” reported in these 
surveys is sometimes questionable, particularly for Russia and Ukraine whose reference 
values were calculated from only two and five samples, respectively. 
A B 
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5.2 LEVELS IN ASIA 
 
Thirty-three articles published between 2000 and 2008, reporting PCDD, PCDF and 
PCB concentrations in human milk samples collected in Asian countries, were identified 
and included in this review.  
In China, most of the studies were conducted in the coastal provinces from northern 
Liaoning to southern Guangdong (Kunisue et al., 2004a; Sun et al., 2005 and 2006;  
Hedley et al., 2006 ; Hui et al., 2007 ; Zhao et al., 2007; Li et al., 2009). Concentrations of 
the contaminants generally varied widely. For instance Hedley et al. (2006) and Hui et al. 
(2007) independently recruited two comparable groups of primiparous mothers in Hong-
Kong in 2001, but found substantially different PCDD/F and dioxin-like (DL) PCB levels in 
their milk (mean WHO-TEQ were respectively 8.25 and 4.67 pg/g fat). Moreover, these 
studies reported substantially lower TEQ PCDD/F levels than those measured in 2000-
2003 in samples from the cities of Shijiazhuang and Tangshan (Hebei Province, northern 
China) (Sun et al., 2005 and 2006) where TEQ for PCDD/Fs were respectively 19 and 13 
pg/g fat. In Korea, Yang et al. 2002 measured PCDD/Fs and DL-PCBs in human milk 
samples from primiparous to identify differences between an industrial (Inchon) and an 
urban (Seoul) area. PCDD/Fs in milk were 1197 pg/g fat in Seoul and 467 pg/g fat in 
Inchon. Values in this study were higher than those reported in northern China (Sun et al., 
2005 and 2006; Li et al., 2009), and substantially higher than in Japan.  
For Japan there were several papers dealing with PCDD/Fs and PCBs in human milk 
published after 2000 (Yoshida et al., 2000; Sampei, et al., 2002; Takekuma et al., 2004; 
Tajimi et al., 2005; Saito et al., 2005; Sun et al., 2006;  Sasamoto et al., 2006a and 2006b; 
Kunise et al., 2006; Guan et al., 2006; Uehara et al., 2006; Tanabe et al., 2007;  Uehara et 
al., 2007; Mato et al., 2007; Nakamura et al., 2008; Todaka et al., 2008). Overall, more 
than 1000 primiparous and multiparous mothers were recruited in Japan from 1997 to 
2004. Detailed results are reported in Table 11A and 11B in the end of this chapter. In 
1997-2002 Uehara et al. (2006) collected 839 milk samples from primiparous and 
multiparous mothers living in various Prefectures in Japan and investigated the 
relationships between mothers’ ages and number of deliveries and PCDD/F 
concentrations in their milk. Mean levels of PCDD/Fs and DL-PCBs in the general 
population were respectively 14.2 and 8.8 pg TEQ/g fat and WHO-TEQ for PCDD/F were 
respectively 8.8 and 14.4 pg/g fat for multiparous and primiparous mothers. Findings were 
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similar for DL-PCBs, with WHO-TEQ of 8.6 and 5.7 pg/g fat for multiparous and 
primiparous mothers. Several studies were done in Taiwan (Hsu et al., 2007; Chao et al., 
2004; Wang et al., 2004). In 2000-2001 Hsu et al. (2007) recruited young mothers with a 
mean age of 28 years, representative of the general population of southern Taiwan. Levels 
of PCDDs and PCDFs in their milk were respectively 8.37 and 6.33 pg WHO-TEQ/g fat.  
In the Philippines, Vietnam, Cambodia, India, Malaysia and Indonesia studies were carried 
out by Tanabe et al. (2007), Sudaryanto et al. (2005 and 2006), Devanathan, et al. (2009), 
Subramanian et al. (2007), Kunisue et al. (2004a and 2004b), Minh et al. (2004). Only 
scant information is available on human exposure to POPs in these countries but the 
population is thought to be exposed to relatively high levels of contaminants, because of 
the fast industrial development. Sampling in these countries were therefore conducted 
mainly in the proximity of open dumping sites and concentrations of PCDD/Fs and DL-
PCBs ( pg TEQ/g fat) were 21 and 16.3 in India, 5.6 and 3.6 in Cambodia, 6.0 and 7.5 in 
Vietnam, 7.5 and 4.4 in Philippines (Kunisue et al. 2004b). Levels were thus quite high in 
India but not in the other countries investigated. Dwernychuk et al. (2002) reported higher 
levels of PCDDs by in the Aluoi Valley in Vietnam, where the US Air Force systematically 
spread Agent Orange in 1965-1966. Concentrations of TCDD in human milk were in the 
range 2.97-14.62 pg I-TEQ /g fat, contributing 51.7%-96.3% to total I-TEQs for dioxin and 
DL-compounds. 
Extensive investigations were also conducted in Northern Russia, particularly in the Kola 
Peninsula and around the White Sea (Polder et al.1998; 2003; 2008), in Siberia (Schecter 
et al., 2002), in the Samara Region (Revich et al., 2001), in the Republic of Buryatia 
(Tsydenova et al., 2007) and Uzbekistan (Ataniyazova et al., 2001). Results are shown in 
Table 12 below. 
Murmansk Arkhangelsk Kargopol Severodvinsk  Naryan-Mar Angarsk 
Usolye 
Sibirskoye 
Chapaevsk 
 
1993 2000 1996 2002 1996 2002 1996-1997 1996-1997 1998 1998 1997-1998 
ΣTEQs of PCDDs/Fs 18 10 15 5 11 12 N.A N.A (10.1-33.2) (16.31-38.43) 42.26 
ΣTEQs of non-ortho PCBs 12 6 10 3 7 7 N.A N.A (5.3- 23) N.A N.A 
ΣTEQs of mono-ortho PCBs 18 13 15 7 11 15 16.59a 17.66a N.A N.A N.A 
 
Table 12 Mean TEQ for PCDDs/Fs, non-ortho and mono-ortho PCBs in breast milk samples from Northern 
Russia (pg/g fat) (Polder et al., 2008; Polder et al., 2003; Polder et al., 1998; Schecter et al., 2002;  Revich et 
al., 2001; Tsydenova et al., 2007) a Sum of PCBs congeners 105, 114, 118, 156, 157, and 189. N.A = not 
analysed 
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Levels of PCDD/Fs were particularly high (42.26 pg WHO-TEQ/g fat) in milk of mothers 
living around the contaminated area of Chapaevsk, near a chemical plant producing crop 
protection chemicals, but the concentrations of PCBs were the highest in samples from the 
areas of Severodvinsk and Naryan-Mar, with maximum values of 16.59 and 17.66 pg 
TEQ/g fat, respectively. Such high level were probably related to the heavy 
industrialization of the White Sea area, resulting in considerable pollution of the 
environment. Particularly high levels of 2,3,7,8-TCDD (16.10 pg WHO-TEQ/g fat) were 
detected in milk samples from Uzbekistan, near the Aral Sea, in concomitance with several 
factors, including heavy use of DDT  in that area (Ataniyazova et al., 2001). The results of 
all these studies are summarized in Table 11A and 11B in the end of this chapter. 
5.3 LEVELS IN EUROPE 
Among European countries relatively high levels of PCDDs, PCDFs and PCBs in 
human milk were reported in Sweden. A study published in 2000 (Noren et al 2000) 
summarized 30 years of investigations in Sweden on PCDDs, PCDFs, PCBs and other 
persistent organic pollutants in human milk. Mean concentrations in samples collected in 
1996-1997 were 14.66 pg WHO-TEQ/g fat for PCDD/Fs and 14.76 pg TEQ/g fat for PCBs. 
These high values were believed to be caused by a diet rich in fish. Similar results were 
found by Glynn et al. (2001), who reported 18.9 pg WHO-TEQ/g fat for PCDD/Fs, and 8.95 
pg TEQ/g fat for DL-PCBs. Data from Norway (Polder et al., 2008a) indicated quite low 
levels of mono ortho PCBs in Tromso and Oslo, respectively 0.7 and 0.9 pg WHO TEQ /g 
fat. 
In Spain and Portugal some monitoring studies of PCDD/Fs and DL-PCBs in human milk 
were conducted in groups of mothers living in the proximity of hazardous wastes 
incinerators (HWI) (Schuhmacher et al., 2002, 2004a, 2004b, 2007 and 2009; Reis et al., 
2007, Marti-Cid et al., 2008). These studies indicated that the mothers were not over-
exposed to PCDD/Fs and DL-PCBs. Mean PCDD/F levels in the milk of these mothers and 
control mothers in Portugal were in fact 9.1 and 9.5 pg WHO-TEQ/g fat respectively (Reis 
et al., 2007).  A recent study (Schumacher et al., 2009) compared levels in three different 
periods (1998, 2002 and 2007) in Tarragona, Spain. Samples collected in 2007 had levels 
of PCDD/Fs and DL-PCBs of respectively 7.6 and 4.8 pg WHO-TEQ/g fat. Comparison 
with concentrations measured in 2002 and 1998 by the same group and in the second 
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round of the WHO coordinated exposure study in Spain confirmed a time-related decrease 
of these contaminants in human milk. In Portugal Reis et al. (2007) monitored a group of 
mothers in Lisbon and Madeira. Levels of PCDD/Fs in their milk were 10.6 pg WHO-TEQ/g 
fat in Lisbon and 6.5 pg WHO-TEQ/g fat in Madeira, very similar to those measured in 
Tarragona by Schumacher et al.(2009). 
A study in Greece (Costopoulou et al., 2006) showed PCDD, PCDF, and DL-PCB levels in 
human milk of respectively 3.66, 3.61, and 6.56 pg TEQ/g fat, suggesting that exposure to 
these compounds in some Southern European countries might sometimes be lower than in 
northern Europe.  However this does not seem a general rule. In fact studies in Italy, 
particularly in Milan, Seveso (Weiss et al., 2003), Rome and Venice (Ingelido et al., 2007, 
Abballe et al., 2008) reported concentrations of PCDD/Fs and DL-PCBs in human milk 
much higher, with levels of  PCDD/Fs and DL-PCBs respectively (pg TEQ/g fat) 9.40 and 
11.01 in Rome, 13.7 and 19.21 in Venice, 10.67 and 6.02 in Seveso, and 11.74 and 8.03 
in Milan.  
In Central Europe studies have been conducted in Germany (Wittsiepe et al., 2007; 
Wilhelm et al., 2007; Cao et al., 2008, Raab et al., 2007 and 2008), Belgium (Focant et al, 
2002), Latvia (Bake et al., 2007), and the Czech Republic (Bencko et al., 2004). A large 
study was recently done in Duisburg and Munich (Germany). Mean levels in human milk 
collected in these two cities were 13.30 and 8.17 WHO-TEQ pg/g fat for PCDD/Fs and 
12.60 and 6.31 WHO-TEQ pg/g fat for DL-PCBs. concentrations were higher  in Liege 
(Belgium), with mean values of 29.4 pg TEQ/g fat for PCDD/Fs and 11.5 TEQ pg/g fat for 
DL-PCBs. In another monitoring study in seven cities in the Czech Republic, PCDD/F and 
DL-PCB concentrations in human milk were quite high, in the range of 11.52-23.90 and 
17.6-70.3 pg WHO-TEQ/g fat. Levels of DL-PCBs were particularly high in samples from 
inhabitants of the polluted area of Uherske Hradiste. In Latvia too, milk samples from the 
highly polluted area of Olaine (Bake M. A, et al, 2007) had extremely high levels of DL-
PCBs (152.25 pg TEQ/g fat), but strangely enough, still higher levels (191.38 pg WHO-
TEQ/g fat) were also given for a control group of mothers living 10 km or more from the 
polluted area. Detailed results from all these studies are shown in Table 11A and 11B in 
the end of this chapter 
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5.4 LEVELS IN AMERICA AND AUSTRALIA  
 
Harden et al. (2007) measured  PCDD/Fs and DL-PCBs in human milk sampes 
collected in 2002-2003 in 12 regions of Australia. Mean levels, expressed as WHO-1998 
TEQs were 5.7 pg/g fat for PCDD/Fs, and 3.1 pg/g fat for DL-PCBs, thus confirming that 
the Southern hemisphere is less contaminated than the Northern, as suggested by the 
third WHO exposure study. A study by Bates et al. (2002) in New Zealand by also 
confirmed these findings. Moreover these authors reported that PCDD/F levels in breast 
milk collected in 1998 were about 75% lower than in samples collected ten years before, in 
1988.  
Concerning South America, recent data on concentrations of PCDD/Fs and DL-PCBs in 
human milk were found only for Brazil (Paumgarten et al, 2000). The mean PCDD/F level 
in human milk was 9.7 pg TEQ/g fat. 
It was difficult to find recent data for North America either. Among the latest available, we 
identified only a study published in 2001, concerning samples collected in 1990, with 
PCDD/Fs of 18.8 pg WHO-TEQ/g fat (LaKind et al., 2001), another study reported levels 
measured in samples collected in  2001 in the USA, where PCDD/F and DL-PCBs levels 
were 7.18 and 4.61 pg WHO-TEQ/g fat (Van Leeuwen et al., 2002).  
 
5.5 FACTORS AFFECTING PCDD/F AND DL-PCB LEVELS IN BREAST MILK 
 
Several factor can potentially affect a population’s exposure to PCDD/Fs and DL-
PCBs and therefore the excretion of these contaminants in breast milk. The area where 
the mother lives seems particularly important, as previously discussed. Other variables 
potentially related to PCDD/Fs and DL-PCBs in breast milk are discussed below and 
include the mother’s diet, her age, parity, and smoking habits. The time of the sampling 
also seems important. A time-trend toward a significant decrease in the exposure of the 
population to these contaminants and therefore of their levels in breast milk was 
documented until 2003, and its continuation seems confirmed by the papers cited in this 
review. 
Effect of the diet. Several studies have shown that dietary habits have a strong 
effect on PCDD/F and DL-PCB intakes, and diets rich in fish and seafood have been 
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frequently associated with higher levels in human breast milk (Li et al 2009; Chao et al., 
2003; Polder et al., 2008; Glynn et al., 2001; Noren et al., 2000). However these 
conclusions are not univocal, since a study in Venice and Rome, in Italy, failed to confirm 
the association of PCDD/F and DL-PCB levels with fish intake (Ingelido et al., 2007; Aballe 
et al., 2008) and a further study in Japan did not find any significant correlations between  
levels of the contaminants and the intake of meat and eggs (Takekuma et al, 2004) 
Effect of age and parity. A correlation has been observed between mother’s age 
and PCDD/F and DL-PCB levels in breast milk has been observed. Younger mothers were 
reported to have significantly lower levels of the contaminants in their milk than older 
mothers, probably because of their shorter lifetime exposure (Chao et al., 2004; Sasamoto 
et al., 2006; Kunisue et al., 2006; Guan et al., 2006; Nakamura et al 2008; Nakatani et al 
2005; Uehara et al 2006; Todaka et al 2008; Takekuma et al 2004; Wittsiepe et al 2007; 
Glynn et al 2001). Significant differences were also reported for primiparous and 
multiparous mothers, with lower levels of the contaminants in breast milk of multiparous 
(Figures  7AB). (Minh et al., 2004; Subramanian et al., 2007; Uehara et al., 2006; Yang et 
al., 2002; Todaka et al., 2008; Guan et al., 2006). 
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Figure 7A. Distribution of PCB congeners in breast milk samples. Comparison of levels and profile in 
primiparous and multiparous mothers  and younger or older ones, in Tokyo (Guan et al., 2006) 
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Figure 7B. PCDD/F in breast milk samples. Comparison of levels and distribution in primiparous and 
multiparous mothers  and younger or older donors, in Tokyo (Guan et al., 2006) 
 
Effect of nutrition of the mother during infancy. Nutrition during infancy also 
seemed to affect PCDD/F and DL-PCB levels in milk during lactation, and breast-fed 
mothers had higher levels of the contaminants in their milk than formula-fed mothers. In 
the study by Takekuma et al. (2004) PCDD/F mean levels in milk were respectively 16.31 
and 14.69 pg TEQ/g fat in mothers who had been breast-fed or formula-fed during infancy. 
Similar results were observed for PCBs, with total TEQs for the sum of congeners 77, 126 
and 169 of 6.78 and 5.96 pg/g fat in breast-fed and formula-fed mothers. Breast-fed 
mothers had significantly higher levels of total PCDD/F (p=0.07) and particularly higher 
levels of 2,3,4,7,8-PCDF in their milk (p<0.02) (Figure 8).  
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Figure 8. PCDD/F levels and distribution in milk samples from mothers who had been formula-fed or breast-
fed during infancy (Takekuma et al., 2004). 
 
Effect of smoking. The effect of smoking on PCDD/F and DL-PCB in breast milk is 
still debated  (Uehara et al., 2007; Takekuma et al., 2004; Hedley et al., 2006). However, 
some studies reported significantly lower PCB levels in milk of active smokers than of 
never smokers, and results were similar for PCDD/Fs but with less significant differences 
(Uehara et al., 2007) (Figure 9). Takekuma et al. (2004) reported that total TEQ for the 
sum of PCDD/Fs and DL-PCBs in breast milk were 19.81 pg/g fat in active smokers and 
23.07 pg/g fat in no- smokers (p=0.001), with particularly higher levels of the congeners 
2,3,4,6,7,8-HxCDF and 1,2,3,4,6,7,8-HxCDD (p<0.001). 
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Figure 9. PCDDs/Fs in breast milk of mothers grouped according to age and smoking habits (Uehara et al., 
2007) 
 
Effect of living in urban or industrialized areas. According to Wittsiepe et al. 
(2007) mothers living in industrial areas had particularly high levels of PCDD/Fs and DL-
PCBs in their milk. Li et al. (2009) also reported that inhabitants of urban areas had  higher 
levels in their milk than people living in rural zones, with significant differences for PCDD/F 
(p<0.05 for WHO-TEQ). Another study in Spain (Schuhmacher et al., 2009), compared 
PCDD/F and DL-PCB levels in human milk of mothers living in an urban area with those 
living in an industrial. Samples from subjects in the urban area had a 38% excess of 
PCDD/F and 40% of DL-PCB over those from the industrial area. Yang et al. (2002) in 
Korea reported similar findings. However, still higher PCDD/Fs were found in milk samples 
collected in cities with heavy chemical industries, and manufacturing plants (Schecter et 
al., 2002), where urbanization and industrialization were therefore coexisting. 
 Effect of living near an incinerator or a dump. Several studies investigated the 
effect on PCDD/F and DL-PCB levels in breast milk of living close to  municipal wastes 
and public waste incinerators (Nakatani et al., 2005; Sudaryanto et al., 2006; Tajimi et al., 
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2005; Kunisue et al., 2004a, Subramanian et al., 2007; Tanabe et al., 2007; Zhao et al 
2007; Wang et al., 2004; Reis et al., 2007; Schumacher et al., 2007 and 2009) (See Table 
13). For instance, Tajimi et al. (2005) studied the correlation between the distance of the 
place of residence from waste incinerators and the concentrations of contaminants in milk. 
Samples from 240 volunteers from six Tokyo districts showed no correlations between 
TEQ for PCDDs, PCDFs and DL-PCBs in their milk, and the distance between their home 
and the nearest public or industrial waste incinerator. The only significant relationship was 
a weak correlation (r=0.25) between distances and concentration in milk of some PCDD 
congeners. PCDD/F congener profiles in these samples was similar to those reported in 
milk of mothers living in industrial areas, with a relative abundance of OCDD, 123678-
HxCDD, 23478-PeCDF, and 1234678-HpCDD (Figure 10). In a group of mothers recruited 
in an area near a solid wastes incinerator in Taiwan, Wang et al. (2004) found levels of 
PCDD/Fs and DL-PCBs similar to those in the milk of mothers living in Athens 
(Costopoulou et al., 2006) or in Malaysia (Sudaryanto et al., 2005). The effect of living in 
the proximity of a hazardous wastes incinerator (HWI) was also investigated in Tarragona 
(Spain) by Schuhmacher et al. (2002; 2004a; 2004b; 2007; 2009). The most abundant 
PCDD/F congeners in milk samples collected in 2002 were OCDD (50.9 pg/g fat) followed 
by 1,2,3,6,7,8-HxCDD (27.7 pg/g fat) and OCDF (27.4 pg/g fat) (Figure 10). The total TEQ-
WHO of 11.9 pg/g fat suggests that living near a hazardous wastes incinerator (HWI) does 
not  imply any additional exposure to PCDD/PCDFs. However, comparing the levels in 
milk samples collected in 1998 and 2002 confirmed a strong decrease of PCDD/F and DL-
PCB concentrations in this region (Schuhmacher et al., 2004a). Similar results were 
obtained by Reis et al. (2007) in a study carried out in the proximity of incinerators in 
Lisbon and Madeira (Portugal).  
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Figure 10 PCDD/F levels and distribution in breast milk samples from  mothers living near a hazardous 
wastes incinerator in various countries  
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Figure 11 DL-PCBs levels and congener distribution in breast  
milk samples from mothers living near a hazardous wastes  
incinerator in various countries (Kunisue et al., 2004).  
 
Table 13. PCDDs/Fs and DL-PCBs (pg 
TEQ/g fat) in breast milk samples of 
mothers living near an incinerator. 
Reference/Location PCDDs/Fs DL- PCBs 
Tajimi et al., 2005 /Tokyo 14.9 10.6 
Wang et al., 2004 /Taiwan 7.62 5.19 
Schuhmacher et al., 2002/Spain 11.9 - 
Schuhmacher et al., 2009/Spain 7.6 
4.8(for Co-
PCBs) 
Faitma Reis et al., 2007 / Portugal 9.2 - 
Kunisue et al., 2004 / Cambodia 5.6 3.6 
Kunisue et al., 2004 / Vietnam 6.0 7 
Kunisue et al., 2004 / Philipines 7.5 4.5 
Kunisue et al., 2004 / India 21 17 
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Studies conducted in some Asian developing countries (India, Vietnam, Philippines 
and Cambodia) in the proximity of large open dumping sites (Kunisue et al., 2004c), 
showed that PCDD/F and DL-PCB levels in breast milk collected in this area were not 
significantly higher than in samples collected in Europe, and comparable to those collected 
in countries like Sweden and Germany (Noren et al., 2000; Wittsiepe et al., 2007). In these 
samples, PCDD/F and DL-PCB profiles were similar to those from industrialised countries, 
with a relative abundance of OCDD, 1234678-HpCDD, 23478-PeCDF, and 123678-
HxCDD (Figures 10 and Figure 11); among DL-PCBs the most abundant congeners were 
CB-118, 156, and 105. Milk samples from donors living near an open dumping site were 
also compared with samples from control sites far from the polluted area. In a study 
carried out in India, PCDD/F and DL-PCB levels were significantly different, with total 
WHO-TEQ  levels of 38 pg/g fat at the dump site and 12 pg/g fat at the control site 
(Kunisue et al. 2004a; 2004c). 
Effect of time (time-trend). A time-related decrease in the concentrations of 
contaminants in breast milk was reported in several of the studies reviewed (Raab et al., 
2008; Noren et al., 2000; Schuhmacher et al 2009; Kunisue et al 2004; Nakamura et al 
2008; Bates et al 2002; Polder et al 2008). For instance a marked decrease of  PCDD/Fs 
and DL-PCBs between 1993 and 2002 was described in Murmansk and Arhangelsk, in 
Northern Russia, with 40% and 61% drops in of WHO TEQs for PCDD/Fs and DL-PCBs 
(Figures 12).  
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Figure 12 Time-related changes of PCDD/F and DL-PCB levels in breast milk samples from Murmansk 
(1993 and 2000), and Arhangelsk and Kargopol (1996 and 2000) in Russia (Polder et al., 2008) 
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Similar findings were reported in Sweden (Noren et al., 2000) and Japan (Uehara et 
al., 2006), where this was probably the result of strict regulations and restrictions on the 
use and production of these compounds. Schuhmacher et al. (2009), in a study in Spain, 
provided strong evidence of this decrease showing an overall reduction of 58% for 
PCDD/Fs and 33% for PCBs over the past 18 years. However, some studies confirmed it 
only in primiparous and not multiparous mothers (Uehara et al 2006), while others 
(Schuhmacher et al., 2009) suggested that the tendency is now slowing, and reported 
smaller decrease between 2002 and 2007 than between 1998 and 2002, for PCDD/Fs and 
DL-PCBs.  However, overall comparison of PCDD/F and PCB concentrations in breast 
milk between 1992, 2002 and 2007 as reported in the studies reviewed (Figure 13 and 14), 
seems to confirm that a time-related decrease is still in progress.  
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Figure 13  
Mean PCDD/F levels 
(pg WHO-TEQ /g fat) 
in breast milk samples 
collected in different 
years (from 1992 to 
2008) and locations. 
 
Figure 14  
Mean PCB levels (pg 
WHO-TEQ /g fat) in 
breast milk samples 
collected in different 
years (from 1992 to 
2008) and locations 
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5.6 HISTORY OF BREAST MILK CONTAMINATION IN ITALY SINCE 1970-2010 
 
For this study of particular interest is the detailed information on the contamination 
of breast milk in Italy. Based on literature past studies conducted in Italy , the WHO 
second round of breast milk monitoring (WHO 1998) and implementing the lack of data 
with large Norwegian study of Noren et al 2000  was possible to reconstruct  precisely the 
concentrations of contaminants since 1970 up to nowadays. It is clear that the 
concentration of persistent organic pollutants in Italian breast milk diminished and this 
trend is continuing for PCB and PCDD/Fs. Still between all contaminants the most 
abundant is PCB-153. In Tables 14ABC below are presented respectively the 
concentrations of PCDD/Fs in pg/g fat, DL-PCB in pg/g fat, and PCB Indicators  in ng/g fat. 
  
Year / concentration pg/g 
fat 
1972 1976 1980 1984 1987 1992 1993 1998 1999 2000 2001 2009 Tendency  line 
2,3,7,8-TCDD 5 5 3  4.50 2.00 2.00 1.54 1.25 1.11 1.55 0.11 y = 9E+66e-0.0771x 
1,2,3,7,8-PeCDD 12 7 6 5 7.50 6.00 6.00 3.74 3.31 2.67 3.61 1.54 y = 1E+38e-0.0432x 
1,2,3,4,7,8- HxCDD     3.30 3.10 3.10 2.55 2.47 1.67 1.76 0.72 y = 2E+60e-0.0692x 
1,2,3,6,7,8- HxCDD 42    28.00 33.40 33.40 11.10 9.24 7.08 9.52 4.57 y = 3E+58e-0.0661x 
1,2,3,7,8,9- HxCDD 10 40 31 30 6.40 5.80 5.80 2.58 2.22 1.64 0.37 0.72 y = 4E+99e-0.1144x 
1,2,3,4,6,7,8- HpCDD 160 96 70 69 55.00 32.60 32.60 15.30 12.80 11.40 11.46 4.23 y = 1E+83e-0.0944x 
OCDD 600 400 300 200 231.00 157.80 157.80 65.30 57.40 52.10 49.45 28.29 y = 2E+74e-0.0836x 
2,3,7,8-TCDF 3 3 3 2 4.90 0.90 0.90 0.76 0.67 0.46 0.76 0.20 y = 9E+66e-0.0771x 
1,2,3,7,8-PeCDF 2    0.90 0.40 0.40 0.45 0.40 0.21 0.20 1.45 y = 3E+30e-0.0355x 
2,3,4,7,8-PeCDF 43 29 17 14 21.00 16.90 16.90 11.50 9.39 7.78 8.87 4.81 y = 9E+43e-0.0495x 
1,2,3,4,7,8- HxCDF 13    4.30 5.00 5.00 3.43 2.66 2.21 3.27 2.94 y = 1E+39e-0.0444x 
1,2,3,6,7,8- HxCDF 11    3.20 4.00 4.00 3.04 2.40 1.84 2.40 1.40 y = 3E+46e-0.0531x 
1,2,3,7,8,9- HxCDF 5     0.10 0.10 0.20 0.30 0.05 0.07 0.52 y = 2E+72e-0.0842x 
2,3,4,6,7,8-HxCDF  14 8 8 1.50 1.50 1.50 1.62 1.34 0.88 0.84 0.16 y = 9E+101e-0.1175x 
1,2,3,4,6,7,8- HpCDF 50 20 7 8 7.90 3.00 3.00 1.69 4.43 1.09 1.19 1.37 y = 2E+84e-0.0968x 
1,2,3,4,7,8,9- HpCDF 2     0.20 0.20 0.09 0.13 0.06 0.12 0.08 y= 6E+81e-0.0953x 
OCDF 4 4 5 5  0.50 0.50 1.03 5.16 0.56 1.42 0.82 y = 2E+45e-0.0521x 
WHO TEQ-PCDD/Fs 29.59 19.85 14.57 10.25 18.76 14.41 14.41 8.48 7.28 5.80 7.53 3.42 y = 6E+42e-0.0482x 
 
Table 14A Concentrations of PCDD/Fs in pg/g fat in Italy since 1972-2009 
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Table 14B Concentrations of DL-PCB in pg/g fat in Italy since 1972-2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14C Concentrations of PCB Indicators in ng/g fat in Italy since 1987-2009 
 
This strong decreasing trend might be a result of well functioning legislation, for 
example European Directives on of the reduction of the emission limits of PCDDs/Fs and 
PCBs from waste incineration set by EU Directive 2000/76/EC implemented in 2000, or 
Commission Regulations such as (EC) No 466/2001 and 1881/2006 setting maximum 
levels for certain contaminants in foodstuffs. 
 
The following equation was proposed by Patandin et al. (1999) to estimate PCDD/F 
and DL-PCB intake from breast feeding in newborns and infants: 
[ ] [ ] 795.0
0
017.0
÷







××××= ∫
−
T
t
breastmilk dteTEQBMFVI   
Where 0.95 = fraction of intestinal absorption of PCDD/Fs and DL-PCBs in breast-milk, V = weekly 
consumption of milk, in mL. [The newborn consumes 800 mL milk per day in the first 0-24 weeks (Period 1),  
500 mL per day in the next 24-36 weeks (Period 2), and 400 mL per day in the 36-48 weeks (Period 3)]. 
BMF = milk fat concentration (3%). T = duration of breast feeding in weeks. TEQ = toxic equivalents of 
PCDD/Fs and DL-PCBs expressed as pg/g fat. 7 = average infant’s body weight (BW), in kg. 0.017 = 
percentage used to take to account of a 1.7% weekly decrease in the PCDD/F and DL-PCB concentrations 
Year / ng/g fat  1972 1976 1980 1987 1990 1992 1993 1998 1999 2000 2009 
Tendence line concentration 
of comtaminants in time 
PCB 28 34 22 29 12  3.9 3.9 6.2 2.1 3.5 1.58 y = 3E+77e-0.0886x 
PCB-52 4   3  1.7 1.7 0.33 0.26 0.26 0.28 y = 5E+80e-0.0933x 
PCB-101 11   1.1  1.3 1.3 1.1 0.91 0.59 0.45 y = 3E+71e-0.0824x 
PCB-118 60 46 31  40 31 31 23 16.30 14.10 8.34 y = 2E+41e-0.0462x 
PCB-153 215 197 152 170 150 146 146 130 87 77 21.85 y = 9E+42e-0.0473x 
PCB-138 190 177 134 130 107 116 116 92 66 58 10.72 y = 3E+53e-0.0596x 
PCB-180 80 84 65 90 77 78 78 76 48 56 14.77 y = 2E+28e-0.0307x 
Year / pg/g fat  1987 1992 1993 1998 1999 2000 2001 2009 
Tendency line  
PCB-81     0.0047 0.0042 0.002 0.005 0.08 - 
PCB-77  0.0015 0.0015 0.00713 0.00988 0.00433 0.026 0.07 - 
PCB-123     0.01 0.01 0.02  0.26 - 
PCB-118    22.2 23 14.1  8.34 - 
PCB-114    1.37 1.40 0.891  0.64 - 
PCB-105  8 8 4.470 5.39 2.87  1.55 y = 1E+88e-0.1008x 
PCB-126  0.0636 0.0636 0.078 0.0829 0.0309 0.076 0.03 y = 1E+38e-0.0453x 
PCB 167 6.3   4.970 4.34 2.9  1.00 y = 1E+72e-0.0824x 
PCB 156 20.4   12.50 10.90 0.765  3.51 y = 5E+81e-0.0933x 
PCB 157 4.2   2.41 2.57 14.8  0.85 y = 6E+52e-0.0602x 
PCB 169  0.0371 0.0371 0.054 0.051 0.0309 0.049 0.08 - 
PCB-170 0       7.48 - 
PCB-189 2.4   1.19 0.98 0.671  0.32 y = 2E+80e-0.0925x 
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in the milk of the breast-feeding mother (Patandin et al., 1999; Chao et al., 2004;  Paul et al., 1988;  US 
Department of Health, 2001).  
 
An estimate of PCDD/F and indicator PCBs intake by newborns (0-24 weeks) and 
infants (24-36 and 36-48 weeks) and for the first year of breast feeding was calculated with 
this equation and is presented in Table 15 below, and in Figure 16.  
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Figure 16 Estimation of daily intake for Italian infants since 1972-2009 
 
Year PCDD/F pg WHO-TEQ 
DI 0-24 
weeks 
DI 24-36 
weeks 
DI 36-48 
weeks Average DI 
Indicator 
PCBs [ng/g fat] 
DI 0-24 
weeks 
DI 24-36 
weeks 
DI 36-48 
weeks Average DI 
1972 29.59 79.14 36.24 23.64 54.54 594.00 1588.68 727.39 474.53 1094.82 
1976 19.85 53.09 24.31 15.86 36.59 526.00 1406.81 644.12 420.20 969.48 
1980 14.57 38.97 17.84 11.64 26.86 194.00 518.86 237.56 154.98 357.57 
1984 10.25 27.42 12.55 8.19 18.89 331.00 885.27 405.33 264.42 610.07 
1987 18.76 50.17 22.97 14.99 34.57 406.10 1086.13 497.29 324.42 748.49 
1992 14.41 38.55 17.65 11.51 26.56 374.00 1000.28 457.98 298.78 689.33 
1993 14.41 38.55 17.65 11.51 26.56 377.90 1010.71 462.76 301.89 696.52 
1998 8.48 22.68 10.38 6.77 15.63 350.96 998.51 421.43 301.89 696.52 
1999 7.28 19.48 8.92 5.82 13.43 328.63 878.93 402.43 262.53 605.71 
2000 5.80 15.51 7.10 4.63 10.69 220.57 589.92 270.10 176.21 406.54 
2001 7.53 20.13 9.22 6.01 13.88 209.45 560.18 256.48 167.32 386.04 
2009 3.42 9.14 4.19 2.73 6.30 57.98 155.08 71.01 46.32 106.87 
 
Table 15. Estimation of daily intake for Italian infants since 1972-2009 for PCDD/Fs and PCB Indicartors 
 
The first 24 weeks of breast feeding are considered the period of highest daily 
intake, the average for this period for PCB Indicators was in the range of 155.08-1588.68 
ng/day/kg b.w and for PCDD/Fs in the range 9.14-36.24 pgTEQ/day/kg b.w. For the B 
however no tolerable daily intake TDI or reference dose has been established specifically. 
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The main reason for that is the difficulty to distinguish between effects due to DL- NDL 
PCB congeners as several sensitive effects occur at the same target organs (liver, 
thyroid). Results for PCDD/Fs are much higher than the tolerable daily intake (TDI) 
proposed by WHO, 4 pg TEQ/kg BW/day (Van Leeuwen et al., 2000), and by the 
European Commission, 2 pg TEQ/kg BW/day (EC, 2001). The risks of this exposure, 
however, should not be overestimated  because the TDI refers to life-span exposure while 
lactation is restricted to a limited period. However, this is a further indication that exposure 
of the population to these contaminants might exceed reference limits and that measures 
are needed to reduce it.  
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Table 11A Summary of PCDD/Fs levels in human milk in cited studies 
Reference City / country 
2,3,7,8-
TCDD 
1,2,3,7,8-
PeCDD 
1,2,3,4,7,8- 
HxCDD 
1,2,3,6,7,8- 
HxCDD 
1,2,3,7,8,9- 
HxCDD 
1,2,3,4,6,7,8- 
HpCDD 
OCDD 
2,3,7,8-
TCDF 
1,2,3,7,8-
PeCDF 
2,3,4,7,8-
PeCDF 
1,2,3,4,7,8- 
HxCDF 
1,2,3,6,7,8- 
HxCDF 
2,3,4,6,7,8-
HxCDF 
1,2,3,7,8,9- 
HxCDF 
1,2,3,4,6,7,8- 
HpCDF 
1,2,3,4,7,8,9- 
HpCDF 
OCDF 
WHO 2006 TEQ 
PCDDs/Fs 
WHO TEQ 
PCDD/Fs+DL-
PCBs 
Venice / Italy 
Low Fish Consumption 
1.79 4.17 2.42 12.2 3.26 16.5 68.4 0.62 0.48 12.1 3.3 2.9 1.33 <0.1 1.75 0.06 0.19 14.8 34.14 
Venice / Italy 
Medium Fish Consumption 
1.54 3.74 2.55 11.1 2.58 15.3 65.3 0.76 0.45 11.5 3.43 3.04 1.62 <0.2 1.69 0.0937 1.03 13.70 32.91 
Venice / Italy 
High Fish Consumption 
1.25 3.31 2.47 9.24 2.22 12.8 57.4 0.67 0.4 9.39 2.66 2.4 1.34 <0.3 4.43 0.13 5.16 11.6 24.93 
Abballe, et al., 2007B 
Roma/ Italy 1.11 2.67 1.67 7.08 1.64 11.40 52.10 0.47 0.21 7.78 2.21 1.84 0.89 <0.05 1.09 0.06 0.56 9.40 20.41 
Ataniyazova, et al., 2001 B Republic of Uzbekistan 16.10 4.84 1.00 2.98 0.79 4.71 20.70 0.48 0.32 3.90 1.84 1.57 0.92 <0.05 1.26 0.06 0.18 23.15 23.15 
Bates, et al., 2002 B New Zeland 1.22 2.53 NA NA 2.28 13.02 67.87 0.20 0.19 2.16 NA NA NA 0.16 1.20 0.20 0.68 4.83 4.83 
Bake, et al., 2007 B Olaine/ Latvia 1.41 1.61 0.53 2.14 0.58 3.1 21.7 0.54 0.4 6.49 1.48 1.22 0.43 <0.04 1.04 <0.035 0.33 5.72 5.92 
Uherske Hradiste/ Czech 
Rep. 
1.84 3.73 1.36 6.63 1.77 8.87 41.5 2.29 1.19 31.03 9.66 5.46 2.16 0.6 6.38 0.47 2.72 18.08 47.09 
Prague/ Czech Rep. 5.83 3.86 1.85 9.07 2.75 16.03 82.1 2.31 0.89 20.5 6.84 5.15 2.01 0.41 6.13 0.74 4.6 19.16 34.83 
Usti n.L/ Czech Rep. 1.94 3.86 2.19 8.87 3.26 12.3 54.1 5.95 2.97 22 12.6 6.88 4.42 0.25 8.38 0.86 2.48 17.16 36.74 
Kolin/ Czech Rep. 1.72 3.19 1.52 7.59 2.23 14.3 75.5 1.95 0.87 17.8 5.84 4.14 1.66 ND 3.34 0.16 2.3 12.97 26.91 
Liberec/ Czech Rep. 1.62 2.21 0.89 4.45 1.26 6.3 28.5 0.97 0.36 12 3.4 2.49 0.85 ND 1.84 0.13 0.96 8.96 16.83 
Kladno/ Czech Rep. 1.43 2.3 1.31 6.56 1.99 9.51 49.2 2.36 0.84 11.1 4.1 2.7 1.34 0.28 2.9 0.46 3.01 9.29 18.25 
Bencko, et al., 2004 B 
 
Telc/ Czech Rep. 1.19 1.94 0.89 3.95 1.32 7.37 31.4 3.46 2.16 15.3 6.89 3.46 2.31 0.15 5.14 0.25 0.98 10.17 23.15 
Chao, et al., 2004 B (≥29 
years old) Taichung/ Taiwan 0.9 3.05 1.59 10.4 1.78 14.9 166 0.52 0.48 4.69 3.05 1.97 0.82 0.02 2.9 0.13 1.14 7.62 7.62 
Chao, et al., 2004 B (<29 
years old) Taichung/ Taiwan 0.6 2.33 1.07 5.61 1.11 9.3 87.6 0.39 0.41 3.96 2.49 1.63 0.67 <LOD 2.99 0.07 3.92 5.58 5.58 
Istanbul / Turkey  0.29 0.95 2.21 3.2 1.08 22.8 61.2 0.32 0.29 4.9 6.1 4.7 6.1 0.0 31.6 5.10 25.9 5.71 8.24 
Afyon / Turkey 0.41 0.69 1.10 3.2 1.08 7.8 21.9 0.43 0.25 4.9 2.9 2.9 2.3 0.0 10.9 1.49 7.5 4.18 5.67 
K.Maras / Turkey 0.23 0.64 1.80 1.41 0.54 107.8 180.1 0.34 0.60 5.9 6.1 4.4 5.3 0.0 25.0 6.3 20.2 6.10 9.27 
Antalya / Turkey 1.1 0.93 5.8 1.67 0.23 38.81 92.8 0.42 0.72 8.2 12.1 8.2 11.9 0.0 57.1 9.80 47.8 9.64 12.80 
Cok, et al., 2009 B 
Ankara / Turkey 0.46 0.88 4.2 5.5 0.85 12.15 45.3 0.30 0.55 6.0 3.9 4.0 4.6 0.0 17.2 3.3 14.8 5.84 8.74 
Costopoulou, et al., 2006B Athens/ Greece 0.73 2.14 1.1 5.3 1 5 ND 0.5 0.2 6.26 1.6 1.6 0.7 0.2 1.0 ND ND 6.01 10.08 
Focant, et al., 2002 B Liege/ Belgium 2.3 8.3 8 28.8 4.7 26.6 223.2 1.3 0.8 25.2 5.4 6.5 3.2 0.1 5.3 No data No data 24.37 37.20 
Glynn, et al., 2001 B Uppsala/ Sweden 0.95 2.49 1.29 10.54 2.38 20.58 108.5 0.49 0.23 6.95 1.59 1.31 0.67 0.05 2.42 0.07 0.31 7.63 14.27 
Guan, et al., 2006  
B(primiparous) Tokyo/ Japan 1.4 6.05 1.1 19.4 6.0 9.0 100 0.9 0.4 11.16 3.7 4.1 2.8 0.4 2.0 ND ND 14.79 24.05 
Guan, et al., 2006 B 
(multiparous) Tokyo/ Japan 1.09 4.45 1.0 14.2 2.9 8.0 100 1.0 0.6 8.34 2.9 3.3 2.1 0.4 2.0 ND ND 10.97 18.42 
Guan, et al., 2006 B (age 
25-29) Tokyo/ Japan 1.17 4.91 0.8 15.7 2.9 8 100 0.9 0.4 9.2 3.2 3.6 2.4 0.3 2.0 ND ND 11.96 21.22 
Guan, et al., 2006 B (age 
30-34) Tokyo/ Japan 1.32 5.69 1.3 17.9 6.1 9 100 1 0.6 10.3 3.5 3.8 2.4 0.4 2.0 ND ND 13.90 21.33 
Harden, et al., 2007 B Australia 0.8 2.3 1.5 8.6 1.5 10.6 61.2 0.5 0.4 2.5 0.8 0.9 0.4 0.2 1.8 0.1 0.8 5.45 7.57 
Hedley, et al., 2006 B Hong-Kong 1.23 2.76 2.06 5.69 1.69 11 59.5 1.06 0.78 5.03 2.46 1.89 0.1 0.82 1.56 0.07 0.3 7.24 10.31 
Hsu, et al., 2007 B Taiwan 1.91 4.17 4.46 12.3 4.51 15.1 133 2.7 1.4 9.5 4.77 3.3 2.22 1.41 5.53 1.18 5.59 12.80 12.80 
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India 3.3 7.3 4.3 14 6.6 55 200 4.7 4.1 11 6.4 5.9 3.7 <0.6 12 <0.6 1.8 19.38 31.17 
Cambodia 1.2 1.6 1.9 3.3 1.8 8.2 31 1.7 1.7 2.2 2.3 1.4 1.4 0.88 1.9 0.71 1.2 5.10 7.64 
Vietnam 0.8 1.2 1.5 3.1 1.7 6.1 18 1.5 1.5 4.2 3.7 2.8 2.2 <0.6 2.1 0.6 1.1 5.11 9.46 Kunisue, et al., 2004
 B
 
Philipines 0.81 2 3 5.2 3 25 150 2.4 1.4 4.1 3.6 2.7 1.7 0.87 3.3 0.6 1.1 6.66 9.95 
Kunisue,, et al., 2004a B 
(age 26-27) Dalian/ China 0.94 0.91 1.1 2.5 1.6 3.8 29 0.71 0.92 4.1 2.9 2.4 1.8 0.87 2.1 1.2 5.5 4.58 7.24 
Kunisue, et al., 2004a B 
(age 28-29) Dalian/ China 0.65 0.87 0.49 2.7 0.47 3.8 32 0.89 0.68 3.9 2.3 1.8 1.1 0.32 1.8 0.19 0.71 3.79 6.35 
Kunisue, et al., 2004a B 
(age 30) Dalian/ China 0.87 0.85 1.3 3.1 0.73 4 40 1 0.82 4.9 3.2 2.2 1.8 0.85 1.6 0.91 2.6 4.71 7.44 
Kunisue, et al., 2004a B 
(age 25-28) Shenyang/ China 0.8 0.94 1 1.8 0.79 2.7 29 1.1 0.64 4.4 2.4 2.1 1.1 0.4 1.8 0.69 0.79 4.21 6.29 
Kunisue, et al., 2004a B 
(age 29-32) Shenyang/ China 0.5 0.64 0.44 1.3 0.52 1.8 15 0.63 0.22 3.2 2.2 1.7 0.43 <0.3 1.1 <0.4 <.5 2.90 5.14 
Kunisue, et al., 2006 B 
(multiparous) Fukoka/ Japan 0.82 3.9 2 14 2.3 9.8 110 0.71 0.28 6.2 2.2 2.2 1.2 <0.6 2.4 0.15 0.53 9.27 14.57 
Kunisue, et al., 2006B 
(primiparous) Fukoka/ Japan 1.4 5.7 2.6 19 3 12 100 0.84 0.19 11 3.3 3.2 1.8 0.6 3 0.23 1.1 14.02 21.62 
Nakamura, et al., 2008, B Tohoku/ Japan 0.93 4.18 1.6 12.8 2.3 6.8 43.6 0.73 0.16 6.91 2.1 2.6 1.6 0.04 1.5 0.06 1.6 9.66 15.58 
Nakatani, et al., 2005 B Osaka/ Japan 1.3 5.3 1.7 28.1 5.1 8.3 57.2 0.7 0.3 10.8 3 3.5 1.6 ND 1.5 ND ND 14.33 21.85 
Noren, et al., 2000 B Stockholm / Sweden 2 4 No data 21 5 30 100 ND No data 11 4 3 No data ND 5 1 4 12.99 22.52 
Paumgrtten, et al., 2000 B Rio De Janeiro/ Brasil 0.6 3.9 0.6 21 4.4 117 420 0.3 0.6 1.8 1.8 1.6 NA 0.3 4.9 NA 0.3 9.40 9.40 
Raab, et al., 2008 B Munich/ Germany 0.86 2.84 1.68 7.95 1.44 8.62 39.95 0.26 0.11 8.73 1.91 1.95 0.9 0.01 2.52 0.04 0.27 8.06 13.74 
Revich, et al., 2001 B Chapaevsk / Russsia 23.2 7.88 2.78 26.5 4.27 10.3 426.4 1.87 9.08 6.73 16.97 11.35 3.02 7.88 1.87 1.87 2 41.10 41.10 
Saito, et al., 2005 B Not precisided 1.5 6.3 2 19.3 3.9 11 73.6 0.7 0.5 13.3 4.6 5.5 3.3 0.00 2.3 0.00 0.00 15.89 22.94 
Sasamoto, et al., 2006B 
(sampling 1999-2000) Tokyo/ Japan 1.1 4.9 0.44 16 6.7 7.7 75 1.02 0.42 9.06 3.1 3.2 1.8 0 1.8 0.025 0.17 12.07 17.22 
Sasamoto, et al., 2006 B 
(sampling 2001-2002) Tokyo/ Japan 0.8 3.4 0.71 10 1.5 6.5 48 0.7 0.32 3.4 2 2.6 1.1 0 0.98 0 0 7.18 16.17 
Anagarsk/ Russia 3.3 2.3 no data 0.5 0.1 0.1 ND 0.2 NA 7.4 no data 2.3 NA 0.1 ND NA NA 8.14 9.17 
Schecter, et al., 2002 B 
Usolye-Sibirskoye/ Russia 3.6 2.7 no data 0.4 0.1 ND ND 0.4 0.1 16.7 no data 4.4 ND 0.1 ND ND ND 11.85 11.85 
Schuhmacher, et al., 
2004a B 
Terragona / Spain 1.04 3.79 1.96 27.7 2.75 11.2 50.9 0.37 0.3 6.27 2.17 2 0.07 0.8 1.74 0.07 27.4 10.66 10.66 
Sudaryanto, et al., 2005 B Penang Kedah/ Malaysia 1.1 3.6 1.7 6.4 2.2 15 100 1.2 <0.16 4.1 2 1.6 0.92 NA 2.3 NA NA 7.74 10.84 
Heibei/ China 0.46 0.89 0.54 1.66 0.34 3.08 31.2 0.34 0.34 2.98 1.85 1.25 0.46 0.2 1.16 0.22 0.87 2.97 4.50 
Sun, et al., 2006 B 
Tokyo/ Japan 1.5 6.85 1.97 22.28 2.8 7.71 53.1 0.66 0.39 10.05 2.38 3.2 0.07 2.19 2.51 0.19 0 15.05 20.12 
Tajimi, et al., 2005 B Tokyo/ Japan 1.2 5.3 1.2 16.8 4.5 8.4 72.4 0.9 0.5 9.8 3.3 3.7 2.5 0.7 1.8 0.7 1.5 12.95 21.30 
Takekuma, et al., 2004, B 
not smokers donors 
Saitma/ Japan 1.59 6.49 2.24 19.37 3.79 11.97 75.13 0.83 0.56 13.94 4.71 5.81 3.78 NA 2.41 NA NA 16.50 24.20 
Takekuma, et al., 2004B 
Active smokers donors 
Saitma/ Japan 1.41 5.91 1.61 18.19 3.24 8.46 71.62 0.6 0.4 12.58 4.43 5.7 2.43 NA 2.16 NA NA 14.85 20.84 
Todaka, et al., 2008 B 
(multiparous) Sapporo/ Japan 0.6 2.3 <LOD 6.9 <LD 5 36 <LOD <LOD 4.1 <LOD <LOD <LOD <LOD <LOD <LOD <LOD 4.88 9.04 
Todaka, et al., 
2008,B(primiparous) Sapporo/ Japan 0.7 3.2 <LOD 9.8 <LD 5.9 40 <LOD <LOD 5.4 <LOD <LOD <LOD <LOD <LOD <LOD <LOD 6.57 11.50 
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Seveso / Italy 4.45 2.76 1.39 7.15 1.37 9.13 72.95 <0.82 0.2 5.81 2.59 1.58 0.64 0.12 1.5 0.13 <1.54 10.65 16.89 
Milan/ Italy 1.63 4.06 2.21 12.8 1.78 20.45 169.12 <0.76 0.21 9.71 3.3 2.44 0.85 0.05 1.44 0.12 <1.42 11.30 20.49 Weiss, et al., 2003
B
 
Lombardian Village/Italy 1.58 4.28 2.79 13.07 2.11 20.49 190.39 <0.82 0.19 9.00 3.44 2.47 0.88 0.04 1.41 0.13 <1.54 11.41 19.57 
Wittsiepe, et al., 2007 B Duisburg/ Germany 1.5 4 2.7 11.6 2.3 12.6 70.4 0.28 0.19 10.1 2.7 2.4 1 0.05 1.9 0.08 0.34 11.01 19.30 
Yang, et al., 2002B 
(multiparous, urban zone) Inchon / Korea 0.20 2.46 2.07 13.19 3.17 11.60 167.17 2.42 0.62 7.25 4.99 3.69 2.21 0.00 4.71 0.33 0.90 8.24 8.24 
Inchon/ Korea ND 1.90 3.64 22.12 1.75 34.07 303.89 1.62 1.54 7.87 6.58 5.78 10.91 0.23 28.56 4.93 22.21 10.34 10.34 Yang, et al., 2002
B
 
(primiparous, industrial 
zone) Seoul/ Korea 0.16 1.83 4.45 29.88 7.41 60.95 836.16 18.35 1.72 14.93 15.82 20.08 24.68 8.37 90.17 14.58 47.71 21.35 21.35 
Values expressed as pg/g fat;  ND – not detected;  NA - not analysed;  N CAL – not calculated;  <LOD - below limit of detectio 
Table 11B. Summary of DL-PCBs levels in human milk in cited studies 
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References City / country PCB-77 PCB 81 PCB-126 PCB-169 PCB-105 PCB-114 PCB-118 PCB-123 PCB-156 PCB-157 PCB-167 PCB-189 TEQ-WHO PCBs 
TEQ-WHO 
PCBs 
Venice LC/ Italy 7.13 4.73 78 54 4470 1370 22200 <0.08 12500 2410 4970 1190 19.34 19.34 
Venice MC/ Italy 9.88 4.22 82.9 51.9 5390 1400 23000 <0.09 10900 2570 4340 982 19.21 19.21 
Venice HC/ Italy 9.68 5.67 61 36.2 3770 953 16300 <0.1 7010 1570 3210 613 13.33 13.33 
Abballe, et al., 2007B 
Roma/ Italy 4.33 2.01 38.9 30.9 2870 891 14100 <0.2 7650 1480 2900 671 11.01 11.01 
Bake, et al., 2007C Olaine/ Latvia 3.59 10.22 1.27 2.33 4.33 12.57 9.57 1.87 5.46 7.02 4 1.33 166.52 0.20 
Uherske Hradiste/ Czech 
Rep. 15.6 NA 256.6 111.5 6.47 NA 69.9 NA 65.6 5.15 21.3 7.38 29.01 29.01 
Prague/ Czech Rep. 18 NA 134 75.4 3.9 NA 34.4 NA 23.3 2.73 8.2 2.67 15.67 15.67 
Usti n.L/ Czech Rep. 8.38 NA 174 72.5 2.98 NA 29.1 NA 41.6 3.42 13.1 4.04 19.58 19.58 
Kolin/  Czech Rep. 10.5 NA 123 54.6 3.43 NA 22.6 NA 26.6 2.48 8.73 2.37 13.94 13.94 
Liberec/ Czech Rep. 12.9 NA 66.1 41.6 1.49 NA 14.9 NA 16.2 1.34 4.54 1.59 7.86 7.86 
Kladno/ Czech Rep. 21.9 NA 76.1 44.7 ND NA 17.1 NA 19.9 2.36 ND 2.37 8.96 8.96 
Bencko, et al., 2004 B 
Telc/ Czech Rep 27.7 NA 118 39.2 ND NA 18.7 NA 15.2 2.01 no data 1.24 12.99 12.99 
Istanbul / Turkey  30.9 3.78 20.40 11.4 746.7 169.3 2264 49.3 810 177.4 253.3 83.2 3.05 2.53 
Afyon / Turkey 21.3 1.6 12.1 5.8 595.9 116.7 1742 46.8 499 110.6 164.7 43.8 1.88 1.49 
K.Maras / Turkey 30.4 5.5 27.2 12.4 443.5 84.6 1220 28.6 355 92.2 122.8 43.6 3.29 3.17 
Antalya / Turkey 43.3 4.7 25.0 15.4 974.9 221.2 3000 61.1 1185 251.2 313.1 103.2 3.91 3.16 
Cok, et al 2009B 
Ankara / Turkey 14.6 3.7 24.1 11.4 883 154.3 2600 55.7 725 172.5 269.3 68.5 3.4 2.90 
Costopoulou, et al., 2006 B Athens/ Greece ND ND 28.4 24 2500 340 6900 1100 3720 680 1000 500 4.06 4.06 
Focant, et al., 2002B Liege/ Belgium 45.9 no data 107.7 68.2 NA NA NA NA NA NA NA NA 12.83 12.83 
Glynn, et al., 2001C Uppsala/ Sweden no data ND 53 21 1960 NA 14910 NA 5610 NA 1430 NA 6.65 6.65 
Guan, et al., 2006B (primiparous) Tokyo/ Japan ND ND 75.9 36 2300 740 10900 ND 3580 880 1000 300 9.26 9.26 
Guan, et al., 2006 B (multiparous) Tokyo/ Japan ND ND 61.3 29 1700 540 8300 ND 2640 640 1000 200 7.45 7.45 
Guan, et al., 2006 B (age 30-34) Tokyo/ Japan ND ND 76.1 35 2300 760 10800 ND 3760 900 1000 300 9.25 9.25 
Guan, et al., 2006 B (age 25-29) Tokyo/ Japan ND ND 61.1 29 1800 520 8400 ND 2460 620 1000 200 7.43 7.43 
Harden, et al., 2007B Australia 20.5 3.2 17 7.2 940 220 3400 67 1300 300 380 87 3.1 2.12 
Hedley, et al., 2006 Hong-Kong/ China 3.91 3.27 26.8 12.7 1.24 C 0.25 C 4.59 C <0.02 C <1.88 C 0.38 C 0.73 C 0.14 C 4.67 3.06 
Kunisue, et al., 2006 B (primiparous) Fukoka/ Japan 18 4.3 56 47 2200 670 9600 190 4000 1000 1300 420 6.9 7.60 
Kunisue, et al., 2006B (multiparous) Fukoka/ Japan 13 3.1 40 31 1400 440 6200 120 2600 630 810 290 10 5.31 
Kunisue, et al., 2004aB (age 26-27) Dalian/ China 5.7 3.6 20 18 590 72 2400 35 540 160 210 49 2.9 2.66 
Kunisue, et al., 2004aB (age 28-29) Dalian/ China 8.00 3 19 17 690 130 2800 47 810 230 260 70 2.9 2.56 
Kunisue, et al., 2004aB (age 25-28) Shenyang/ China 2.8 2.3 17 8.8 570 93 2100 31 540 140 170 56 3.2 2.08 
Kunisue, et al., 2004aB (age 29-32) Shenyang/ China 6.6 2.5 19 6 830 94 3400 48 570 120 180 40 2.5 2.24 
Kunisue, et al., 2004aB (age 30) Dalian/ China 5.3 3.3 21 16 820 100 2700 45 700 180 270 71 2.8 2.73 
India 100 36 100 20 7300 860 22000 460 4600 1100 1900 310 16.3 11.79 
Cambodia 18 5.4 21 6.5 1400 210 4400 74 1300 280 350 77 3.6 2.54 
Vietnam 15 5 34 8 4000 590 14000 280 3100 600 820 120 7 4.35 
Kunisue, et al., 2004B 
Philipines 28 9.1 27 12 1400 180 4600 100 340 510 190 10 4.5 3.29 
Nakamura, et al., 2008 B Tohoku/ Japan 3.3 2.1 46.5 27.5 1782 504 8288 112 2460 591 942 184 7.8 5.92 
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Nakatani, et al., 2005 B Osaka / Japan 38.3 6.5 59.4 34.6 1935.3 599.5 9268.1 202.3 3498.3 729 980 243.5 9.9 7.51 
Noren, et al., 2000 B Stockholm/ Sweden 16 N.A 76 39 4000 0 13000 NA 6000 2000 ND NA 9.52 9.52 
Norway / Tromso NA NA NA NA 25000 1200 100000 ND 13400 3200 150000 3000 8.87 8.87 
Norway / Oslo Grunnerlokka NA NA NA NA 32000 2000 140000 ND 22000 5200 220000 7000 12.85 12.85 Polder, et  al., 2008a
B
 
Norway / Oslo Sondre 
Nordstrand NA NA NA NA 35000 1600 150000 ND 13600 3400 190000 4000 11.93 11.93 
Raab, et al., 2008 B Munich/ Germany 5.86 1.49 48.57 27.49 1.64 0.48 9.88 0.1 5.66 0.85 1.71 0.77 6.31 5.68 
Saito, et al., 2005 B Not precised 6.5 NA 59.5 36.6 NA NA NA NA NA NA NA NA N. CAL 7.05 
Sasamoto, et al., 2006 B  sampling 2001-
2002, Tokyo/ Japan 8.1 2.4 40 26 95 6600 1500 410 690 2200 520 180 11 5.15 
Sasamoto, et al., 2006B sampling 1999-
2000, Tokyo/ Japan 30 25 75 32 36 9500 2000 650 1000 3200 780 230 6.6 8.99 
Schecter, et al., 2002 Anagarsk/ Russia nd NA 10.2 0.4 NA NA NA NA NA NA NA NA 10.6 1.03 
Sudaryanto, et al., 2005B Penang Kedah/ Malaysia 19 2.8 22 19 1700 450 5800 120 1800 390 490 140 4.5 3.10 
Heibei/ China 9.97 3.29 12.34 6.07 746.7 92.28 1944 43.37 433.4 94.73 141 36.63 1.88 1.53 Sun, et al., 2006B 
Tokyo/ Japan 4.4 1.72 36.65 35.4 1490 307.3 5420 62.3 2312 807 812.5 227.2 6.48 5.07 
Tajimi, et al., 2005B Tokyo/ Japan 5.5 20.8 68.6 32.3 2018.5 639.6 9555.7 0.4 3111.5 759.4 984.4 230 10.6 8.35 
Takekuma, et al., 2004B (not smokers 
donors) Saitma/ Japan 5.99 NA 65.99 36.57 NA NA NA NA NA NA NA NA 6.97 7.70 
Takekuma, et al., 2004B (active smokers 
donors) Saitma/ Japan 5.79 NA 49.96 32.83 NA NA NA NA NA NA NA NA 5.33 5.98 
Todaka, et al., 2008 B (multiparous) Sapporo/ Japan <LD <LD 33 16 1707 396 7090 108 1953 447 711 186 4.2 4.16 
Todaka, et al., 2008 B (primiparous) Sapporo/ Japan <LD <LD 39 20 1939 480 8075 145 2209 515 801 198 4.9 4.93 
Seveso/ Italy ND 3.00 53 31 NA NA NA NA NA NA NA NA 5.57 6.23 
Milan/ Italy 25 5.00 75 56 NA NA NA NA NA NA NA NA 8.08 9.19 
Weiss, et al., 2003 B 
Lombardian Village/Italy 27 3.00 66 52 NA NA NA NA NA NA NA NA 7.13 8.17 
Wittsiepe, et al., 2007 B Duisburg/ Germany no data no data 67.3 28.9 1800 630 11000 230 6400 870 2000 380 8.29 8.30 
Yang, et al., 2002B 
(industial zone, primiparous donor) Inchon /Korea 75 NA 38 23 1333 294 5348 95 1211 NA NA NA N CAL 4.76 
Yang, et al., 2002, B 
(industrial zone, multiparous donor) Inchon /Korea 39 NA 30 23 1354 264 5236 88 1631 NA NA NA N CAL 3.96 
Yang, et al., 2002B 
(urban zone multiparous donors) Seoul/ Korea 470 NA 29 0 759 93 2757 45 359 NA NA NA N CAL 3.16 
Yang, et al., 2002B 
(urban zone, primiparous donors) Seoul/ Korea 164 NA 51 28 1599 958 5228 156 1485 NA NA NA N CAL 6.27 
Pingqiao/ China 15670 1600 NA NA 4400 7380 5400 NA NA NA NA NA 5.38 5.38 Zhao, et al., 2007C 
Luqiao/ China 5150 NA NA NA 15210 8660 17750 NA 9510 2680 NA NA 3.16 3.16 
Values expressed as pg/g fat;  ND – not detected;  NA - not analysed;  N CAL – not calculated;  <LOD - below limit of detection 
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6. HUMAN BIO-MONITORING OF PCDD/Fs and PCBs IN ITALIAN BREAST MILK 
 
Polychlorinated dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) are by-
products of combustion or thermal processes involving organic matter and chlorine, such 
as those occurring during waste incineration, power/energy generation, metallurgical and 
other chemical–industrial processes as already mentioned in previous chapters (Konig et 
al., 1993; Cleverly et al., 2007), whereas polychlorinated biphenyls (PCBs) are produced 
by industry as technical mixtures for use as dielectric fluids, organic diluents, plasticizers, 
adhesives and flame retardants. As widespread in environment and easily fat soluble they 
bioaccumulate through the food chain and enter the human body mainly via food. They 
accumulate in fatty materials such as adipose tissue and breast milk. Several factors can 
potentially affect a population’s exposure to PCDD/Fs and PCBs, and hence the 
occurrence of these contaminants in breast milk. The most important variables are the 
mother’s diet (Li et al 2009; Chao et al., 2003), her age (Sasamoto et al., 2006; Kunisue et 
al., 2006), parity (Minh et al., 2004; Subramanian et al., 2007; Uehara et al., 2006), and 
smoking habits (Uehara et al., 2007; Takekuma et al., 2004).  
Several studies have shown that concentrations of PCDDs/Fs and PCBs in breast 
milk of mothers living in urban areas are higher than those from rural zones (Yang et al., 
2002; Schuhmacher et al., 2007 and 2009; Li et al., 2009). Particularly high levels of 
PCDDs/Fs were found in breast-milk samples collected near chemical industries and 
manufacturing plants (Schecter et al., 2002). Processes such as combustion of 
municipal/urban waste in incinerators, burning of domestic waste or backyard burning may 
produce optimal conditions for formation and emission of PCDDs/Fs (Gullett et al., 2001). 
However research conducted in the proximity of modern municipal solid-waste incinerators 
and hazardous-waste incinerators (Reis et al., 2007; Schuhmacher et al., 2004a; Tajimi et 
al., 2005) did not show significant increases of PCDDs, PCDFs and PCBs in the milk of 
the mothers potentially exposed. Moreover, according to Tajimi et al. (2005), there was no 
relationship between PCDD/F levels in breast milk and the distance of the mothers’ home 
from the nearest waste incinerator. Indeed living near to a modern well controlled 
municipal solid-waste incinerator or hazardous-waste solid incinerator should not increase 
the risk of exposure to PCDDs/Fs and PCBs (Reis et al., 2007;  Schuhmacher et al. 2002; 
2004a; 2004b; 2007; 2009).  
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Recently the area of Naples, which includes the city of Giugliano, was reported to 
have serious problems regarding the disposal of domestic waste. For a long period, from 
the mid 1980’s until recently, much waste has been disposed of illegally and burned on 
open-air fires; this additional source of PCDDs/Fs might have increased the exposure of 
residents either directly through the atmosphere or indirectly through the food-chain. 
Breast milk is known to accumulate these substances, and its monitoring can show 
whether such possible additional exposure resulted in increased intake. 
 
6.1 Breast milk sampling  
 
A total of 59 healthy mothers, non-occupationally exposed to PCDD/F and PCB, 
were recruited, comprising 21 mothers from Giugliano, 22 from Piacenza and 16 from 
Milan. Breast-milk samples were collected manually by each volunteer from April 2008 to 
November 2009 at one to three months after delivery. Mothers provided informed consent 
and filled in a “questionnaire for human milk donors” as proposed by WHO. The 
information included age, residence record, dietary habits (frequency of consumption of 
fish, meat, eggs, milk, vegetables and fruits), occupation before pregnancy, and smoking 
habits (Tables 16). Samples were collected in glass containers and stored at -20oC until 
analysis.  
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Table 16 Characteristics of milk donors from Piacenza, Milan and Giugliano in Campania,  
 
 
6.2 Materials 
 
PCB internal standards (19 13C12 congeners) were supplied by Cambridge Isotope 
Laboratories (Andover, Massachusetts, USA); PCDD and PCDF internal (16 13C12 
congeners 2,3,7,8 chlorine-substituted) and external standards (2,3,7,8-TCDD 37Cl 
substituted) were supplied by Wellington Laboratories (Shawnee Mission, USA). 
Solvents and reagents such as n-hexane (purity >98%), acetone (>99.8%), 
dichloromethane (>99.8%) and carbon tetrachloride were obtained from Riedel, 
(Germany). Concentrated sulfuric acid (>98%), isooctane (>98%), methanol (99.9%) and, 
diethyl ether (> 99.5%) were obtained from Carlo Erba, Italy. Aluminum oxide for column 
chromatography, anhydrous sodium sulfate (99%), Extrelut NT cartridges and silica gel 
% Piacenza Milano Giugliano in Campania 
Milk Not at all 0 0 5 
 Less than 1/week 0 0 5 
 1/week 5 0 0 
 2/week 5 0 10 
 More than 2/week 36 19 25 
 Every day 55 81 55 
Meat Not at all 0 6 0 
 Less than 1/week 5 6 0 
 1/week 5 6 0 
 2/week 23 25 0 
 More than 2/week 55 50 85 
 Every day 14 0 15 
Fish Not at all 9 6 0 
 Less than 1/week 18 13 5 
 1/week 50 63 40 
 2/week 23 6 45 
 More than 2/week 0 6 10 
 Every day 0 0 0 
Vegetables Not at all 0 0 5 
 Less than 1/week 0 0 5 
 1/week 0 0 10 
 2/week 5 6 0 
 More than 2/week 14 56 60 
 Every day 82 38 20 
Fruit Not at all 0 0 0 
 Less than 1/week 5 0 5 
 1/week 0 0 10 
 2/week 23 13 10 
 More than 2/week 18 44 25 
 Every day 55 38 50 
Eggs Not at all 0 0 25 
 Less than 1/week 59 38 20 
 1/week 18 31 25 
 2/week 23 6 20 
 More than 2/week 0 19 10 
 Every day 0 0 0 
Number of mothers 22 18 21 
Primipara vs multipara 82/18 81/19 100/0 
Younger (age 20-30) vs  
older (age 30-40) 32/68 18/82 85/15 
20-30 years old 39 18 86 
primipara 30-40 years old 61 82 14 
Smoking habits: Yes/No 23/77 31/69 10 /90 
Occupational exposure: Yes/No 14/86 25 /75 25 /75 
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were purchased from Merck (Darmstadt, Germany). Glass wool was obtained from 
Supelco (Bellefonte, PA) and sodium oxalate from Sigma Aldrich (Seelze, Germany) 
 
6.3 Extraction 
 
Breast milk was extracted using a liquid-liquid extraction method, samples (50 ml) 
being placed in a glass beaker with of sodium oxalate (1 g), to prevent coagulation. Then 
internal standards of PCDD/ F (200 pg) [13C12 – 16 isomers] and of PCB (1.00 ng) [13C12 
WHO-PCB 12 dioxin-like PCBs isomers and seven PCB isomers called indicators] were 
added to the sample, and an external standard [2,3,7,8-TCDD Cl37] was added after 
extraction to measure the instrumental recovery. A blank was also included in each series 
of samples. Lipids were liquid-liquid extracted from the aqueous sample with methanol (50 
ml), followed by diethyl ether (3x50 ml) and n-hexane (3x50 ml) with the aid of an 
ultrasonic homogenizer. The extracts were dried by evaporation to constant weight for 
gravimetric fat determination.  
 
6.4 Clean-up 
 
Dried samples were dissolved in 98% sulfuric acid (15 mL per 2.5 g fat), applied to 
an Extrelut column and eluted with n-hexane (120 mL). The solvent was concentrated by 
evaporation to 1 mL, and applied to an alumina column in order to separate PCDDs and 
PCDFs from PCBs. PCBs were first eluted with carbon tetrachloride (6 mL), and 
subsequently PCDDs/Fs and PCBs 77, 81, 126 and 169 were eluted with dichloromethane 
(7 mL)
.
 All extracts were dried with a gentle stream of nitrogen and redissolved in 
isooctane (50 µL) for instrumental analysis. 
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Glass wool
0.5 cm of Na2SO4 anh.
4.5 cm of Al2O3
Glass wool
1)  6 ml of CCl4
2)  7 ml of CH2Cl2
1 2
External standard 2,3,7,8-Cl37
 
 
Figure 17. Alumina column preparation and elution step with using CH2Cl2 and CCl4. 
 
6.5  Instrumental analysis 
 
PCBs (19 congeners, IUPAC No. 28, 52, 81, 77, 101, 123, 118, 114, 105, 126, 153, 
138, 167, 156, 157, 169, 180, 170, 189) and PCDDs/Fs (17 congeners: 2,3,7,8-TetraCDD, 
1,2,3,7,8-PentaCDD, 1,2,3,4,7,8-HexaCDD, 1,2,3,6,7,8-HexaCDD, 1,2,3,7,8,9-HexaCDD, 
1,2,3,4,6,7,8-HeptaCDD, OctaCDD, 2,3,7,8-TetraCDF, 1,2,3,7,8-PentaCDF, 2,3,4,7,8-
PentaCDF, 1,2,3,4,7,8-HexaCDF, 1,2,3,6,7,8-HexaCDF, 2,3,4,6,7,8-HexaCDF, 
1,2,3,7,8,9-HexaCDF, 1,2,3,4,6,7,8-HeptaCDF, 1,2,3,4,7,8,9-HeptaCDF, OctaCDF) were 
measured by high-resolution gas chromatography-high-resolution mass spectrometry 
(HRGC-HRMS) using a TRACE GC 2000, Thermo Finnigan (Thermo Fisher Scientific), 
coupled with a Mat 95 XP Mass Spectrometer, operating in the electron impact ionization 
(EI+) mode at resolution 10000. 
For PCDD/F analysis, the following temperature program was used: 160 °C for 1 min, 2.5 
°C/ min increase to 300 °C, 300 °C maintained for 6  min. Peaks were accepted if the 
isotopic ratio was within 15% of the corresponding ratio in the IS. To calculate the limit of 
detection (LOD), the minimum signal-to-noise ratio considered was 3:1. Recoveries were 
in the range 70-90%. Concentrations of most compounds were higher than the LODs, 
except for 2,3,7,8-TCDD and 2,3,7,8-TCDF in some samples. Concentrations below LOD 
were assigned a value of LOD/2 (middle bound). TEQ values were calculated using 
revision 2006 WHO-TEFs.  
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PCBs were analysed using a BPX-DXN (60 m x 0.20 mm x 0.25 µm) (SGE, Analytical 
Science, Melbourne, Australia) capillary column with splitless injection and the following 
temperature programme: 125 °C for 2 min, 8° C/min i ncrease to 190 °C, 2 °C/ min 
increase to 280 °C, maintained for 7 min. The GC-MS  was used in the selected-ion 
monitoring (SIM) mode and the monitored ions for PCBs and dioxins were M- and (M+2)- 
for tetra- and penta-substituted compounds, and (M+2)- and (M+4)- for hexa-, hepta- and 
octa-substituted. 
 
6.6  Results 
 
PCDDs, PCDFs and  PCBs in milk: comparison of samples from Giugliano vs. Milan 
and Piacenza. 
 
The mean concentration of PCDDs/Fs in milk samples collected in Giugliano was 
46.6 pg/g fat, this being slightly lower than that in samples from Milan (51.5, p=N.S.) and 
Piacenza (57.0, p=0.05) (Table 17). The mean total WHO-TEQ value was also lower in 
samples from Giugliano (3.78) than from Milan (5.03, p=N.S.) and Piacenza (4.67, 
p=0.05). 
 Piacenza Milan Giugliano in Campania 
Summary mean range S.D mean range S.D mean range S.D 
PCDDs [pg/g of fat] 40.19 8.72-132.49 31.36 36.39 15.22-57.17 12.17 33.14 15.79-69.68 14.01 
PCDFs [pg/g of fat] 16.76 4.41-37.95 7.89 15.16 9.34-31.28 7.38 13.49 5.24-46.33 9.82 
PCDDs+PCDFs [pg/g of fat] 56.95 20.46-145.76 33.00 51.54 24.56-85.98 16.95 46.64 27.08-96.99 21.03 
WHO-TEQ PCDDs+PCDFs 4.67 2.43-7.70 1.44 4.70 2.42-9.55 1.80 3.78 1.26-9.44 2.09 
          
DL-PCBs [ng/g of fat] 48.65 14.87-116.46 30.68 31.48 9.20-76.13 21.69 37.31 16.92-86.83 16.34 
PCBs Indicator [ng/g of fat] 113.69 26.95-267.37 70.00 65.47 19.85-192.47 55.13 72.42 23.59-160.49 29.20 
PCBs (DL-PCBs+Indicators) 130.98 36.01-297.45 76.61 82.18 26.29-245.26 67.86 94.15 45.96-207.51 36.60 
WHO-TEQ DL-PCBs 5.27 1.47-10.70 2.64 6.28 1.09-9.19 3.317 4.87 1.81-10.46 2.21 
Total WHO-TEQ PCDDs/Fs+DL-PCBs 9.94 5.58-17.59 3.10 10.98 4.66-14.15 4.39 8.65 4.22-18.95 3.55 
 
Table 17 Summary: mean and range of PCDD, PCDF and PCB concentrations in human milk collected in 
Piacenza Milano and Giugliano. 
 
Analysis of the PCDD/F congener profiles showed that OctaDDs and 2,3,4,7,8-
PentaCDF, followed by 1,2,3,6,7,8-HexaCDD and 1,2,3,4,6,7,8- HeptaCDD were the 
congeners with the highest concentrations in milk (Table 18- in the end of the chapter). 
Significant differences were observed for 1,2,3,7,8-PeCDF levels, which were much lower 
 52 
in Giugliano (0.16 pg/g fat) than in Milan (0.89 pg/g fat, p=0.03) and Piacenza (4.46 pg/g 
fat, p=0.02). The congeners principally contributing to the total TEQ were always 1,2,3,7,8-
PentaCDD and 2,3,4,7,8-PentaCDF (altogether 64-71% of the total), but only small 
differences in the PCDD/F profiles were observed in milk samples collected at the different 
locations. (see Figure 18 and 19). Whereas samples from Piacenza and Milan had 
comparable profiles with the highest contribution to total PCDDs/Fs given by PentaCDDs 
and PentaCDFs followed by HexaCDDs and HexaCDFs, in the Giugliano samples the 
highest contributions were given by PentaCDFs and PentaCDDs, followed by TetraCDD 
and HexaCDDs (See Table 18- in the end of this chapter, 18 and 19).  
Table 18 shows also DL-PCB and the indicator PCB concentrations in milk. PCB congener 
profiles in the three groups were generally comparable. The most abundant congeners 
were PCB-170 and PCB-118 followed by PCB-156 among DL-PCBs, and PCB-153, PCB-
180 and PCB-138 among the indicator PCBs.(See Figure 20) Total PCB concentrations 
were higher in samples from Piacenza (131 ng/g fat) than from Milan (82.2 ng/g fat, 
p=0.03), and Giugliano (67.9 ng/g fat p=0.05), but total WHO-TEQs for PCBs were higher 
in Milan (6.28 ng TEQ) than in the other two cities (Tables 17 and 18, Figure 18). The 
major contribution to total TEQs for PCBs was from PCB-126, followed by PCB-169. PCBs 
with 6- and 7-chlorines were the most abundant classes in all the three groups (Figure 20). 
Samples from Giugliano had the highest level of hexachloro PCBs but differences were 
not statistically significant. 
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Figure 18. PCDD/Fs congener profiles in breast milk from  Piacenza, Milano and Giugliano in Campania 
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Figure 20 DL-PCB and PCB Indicators in milk samples from Piacenza, Milan, and Giugliano in Campania 
 
Principal Component Analysis was performed to investigate the relationships 
among PCBs and PCDDs/Fs concentrations and profiles in milk and some variables, 
including location, diet, age, and smoking habits of donors. A significant correlation was 
found only between PCBs in milk and location. The score and loading plots are shown in 
Figure 21 A and B. The first, second and third principal components accounted for 
respectively 34%, 16% and 12.7% of the variability of the data set. The first component 
was positively influenced by PCB-123, PCB-157, PCB-77, PCB-81, and PCB-52, and 
negatively influenced by PCB-138. The second component was positively influenced 
mainly by PCB-118, whereas PCB-189 and PCB-153 were related to the third component. 
Score plots (Figure 21A) allowed the identification of at least two clusters. Samples 
marked “G” (from Giugliano) were all grouped in cluster 1 and were separated through the 
first and third component. Samples grouped in cluster 2 were of different origin, mostly 
from Piacenza but some also from Milan. The second component was responsible for the 
separation of only few samples collected in Milan and Piacenza from the others (Figure 
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21A, dotted line circle). When the first principal component is plotted against the third, 
three groups of samples can be better distinguished, and cluster 1 is clearly separated 
(Figure 21B). The PCB profile was similar in samples from Milan and Piacenza but differed 
in samples from Giugliano. This explains the grouping of all the samples from Giugliano in 
cluster 1 of the PCA score plots, and the presence of mixed samples from the other two 
cities in cluster 2 (Figures 21A,B). The major differences in the samples from Giugliano 
were given by PCB-123 and PCB-157 which occurred at very low concentrations and by 
PCB-81 and PCB-77 which were frequently at concentrations below the LOD. Congener 
PCB-189 was also detected at lower concentrations in milk samples from Giugliano and 
this might explain the cluster separation in the third principal component (Figure 21B). 
Overall the Principal Component Analysis showed that samples collected in Giugliano 
were homogenous for their PCB profiles, whereas samples collected in Piacenza and 
Milan had greater differences. 
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Figure 21 A PCA score and Loading plots of 59 samples and 19 viariables (19 PCB congeners). First and 
second PC; 
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Figure 21B PCA score and Loading plots of 59 samples and 19 viariables (19 PCB congeners) First and 
third PC 
 
Effect of diet and age on PCDD/F and PCB levels in breast milk 
 
Samples collected from the different locations were grouped in order to analyse the 
effect of diet and age on contaminants level and profile. Based on questionnaire 
information, donors were divided into groups considering age (age groups 20-30 and 30-
40 years) and dietary habits (high or low fish and meat consumption). PCDD, PCDF and 
PCB mean concentrations in milk samples from these subgroups are presented in Table 
16. Age was significantly related to PCDD/F concentrations and older mothers had higher 
level of PCDDs/Fs in their milk than younger mothers (65.9 pg/g fat and 47.7 pg/g fat 
respectively, p=0.03). Statistically non-significant differences were observed for PCBs in 
 59 
milk (4.98 and 5.36 ng WHO-TEQs respectively for young and old mothers; Table 19 and 
Figures 22A,B). No significant correlations were observed between consumption level of 
meat and fish and concentrations of these contaminants in breast milk. 
Other dietary variables collected through the food-frequency questionnaire, such as 
consumption of milk and dairy products, vegetables, and fruits, and other potential 
variables such as the smoking habits and the delivery history of the donors, could not be 
investigated because of an insufficient number of subjects in some experimental groups. 
 
PCDDs/Fs pg/g of fat 20-30 year old 30-40 year old Meat HC Meat LC Fish HC Fish LC 
mean 47.67 65.8 56.19 37.24 46.50 52.39 
St.Dev 21.85 35.16 29.91 0.62 21.65 22.66 
Rel.St.Dev 0.45 0.53 0.53 0.02 0.47 0.43 
Std.Err 4.37 7.67 5.29 0.36 5.41 9.25 
p value 0.03  0.29  0.58  
PCBs ng/g of fat 20-30 year old 30-40 year old Meat HC Meat LC Fish HC Fish LC 
mean 87.08 107.58 104.77 99.13 104.43 82.06 
St.Dev 41.69 65.93 50.39 53.95 48.46 30.69 
Rel.St.Dev 0.48 0.61 0.48 0.54 0.46 0.37 
Std.Err 8.18 14.05 8.77 24.13 0.11 13.73 
p value 0.19  0.82  0.34  
PCDDs/Fs pg TEQ-WHO 20-30 year old 30-40 year old Meat HC Meat LC Fish HC Fish LC 
mean 3.94 4.90 4.22 4.29 4.28 4.08 
St.Dev 1.94 1.72 2.02 0.94 2.30 0.70 
Rel.St.Dev 0.49 0.35 0.48 0.22 0.54 0.17 
Std.Err 0.38 0.38 0.30 0.55 0.57 0.31 
p value 0.07  0.95  0.84  
PCBs pg WHO-TEQ Eq. 20-30 year old 30-40 year old Meat HC Meat LC Fish HC Fish LC 
mean 4.99 5.37 4.94 5.33 5.09 4.48 
St.Dev 2.61 2.62 2.51 3.84 2.34 2.14 
Rel.St.Dev 0.52 0.49 0.51 0.72 0.46 0.48 
Std.Err 0.51 0.57 0.46 1.72 0.59 0.96 
p value 0.61  0.76  0.61  
 
Table 19. Correlations between age and dietary habits of donors and concentrations of dioxins and PCBs. 
Abbreviations: St.Dev – standard deviation; Rel.St.Dev – relative standard deviation; Std.Err – standard 
error; p-value – student t-test; HC indicate high consumption ,LC indicate low conssuption 
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Figure 22 Correlations between age and dietary habits of donors and concentrations of dioxins and PCBs 
A expressed in pgTEQ-WHO , B in pg/g fat 
 
 
6.7 DISCUSION 
 
The main aim of this study was to investigate if the burning of wastes on open-air 
fires, as frequently occurs around the city of Giugliano, had resulted in an increase of 
PCDDs and PCDFs in the breast milk of local mothers. Milk samples of donors recruited in 
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Giugliano were compared with those of donors from two cities with different sources of 
pollution, Piacenza and Milan, for their PCDD and PCDF levels and profiles. PCBs were 
also measured as another group of polycyclic aromatic compounds entering the human 
body mainly via the food chain, as for PCDDs and PCDFs, but which are not produced by 
combustion. Other possible confounding variables such as diet, age and smoking habits of 
donors were also investigated. 
Neither PCDD and PCDF levels nor WHO-TEQs in milk samples collected in Giugliano 
were significantly lower than those taken in Piacenza and Milan, indicating a lack of effect 
of open-air burning of wastes on the accumulation of these contaminants in breast milk. 
PCB levels and WHO-TEQ values of DL-PCBs were also slightly higher in samples from 
Piacenza and Milan than in those from Giugliano. However, apart from these slight 
differences, the findings were generally homogeneous and this allows us to conclude that 
these levels measured in breast milk resulted from a typical dietary intake of a general 
non-occupationally exposed population. The higher content of PCDDs/Fs and PCBs in 
milk samples collected in Milan and Piacenza might be a result of a greater contamination 
related to industrial activities or vehicular traffic in these cities but might be also related to 
the older age of the donors, at least in Milan (Table 17 and 18). Indeed our study 
confirmed the existence of a relationship between levels of these contaminants in breast 
milk and the age of the mothers, as reported by others (Sasamoto et al., 2006; Kunisue et 
al., 2006). 
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Figure 23 Comparison of PCDDs PCDFs and PCBs in breast milk from different Italian cities with recent 
study 
 
Previous surveys of PCDDs/Fs and PCBs in human milk in Italy have been conducted in 
Rome and Venice in 1998-2001 (Ingelido et al., 2007; Abballe et al., 2008), in Milan and 
Seveso in 2000-2001 (Weiss et al., 2003) and in Milan in 2000-2001 during the second 
series of the international exposure study carried out by the WHO (Van Leeuwen et al., 
2002). PCDDs/F and PCB levels in breast milk measured in this study were lower than 
those reported in these previous studies (Figure 23),  and this study confirms the existence 
of a time-related trend of decrease of these contaminants in human milk, with a 57% and 
20.5% decrease of the WHO-TEQ values for PCDDs/Fs and DL-PCBs respectively in the 
last 10 years (Weiss et al., 2003) and an 80% decrease in the last 20 years (WHO, 1987). 
In conclusion, mothers from Piacenza, Milan and Giugliano in this study seem to be 
exposed to lower doses of PCDDs/Fs and PCBs; and this might be a result of strict 
regulations and restrictions on the use and production of these compounds, as previously 
noted (Uehara et al., 2006; Noren et al., 2000).  
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 Piacenza (22 samples) Milan (16 samples) Giugliano  in Campania(21 samples) 
Pg/g of fat 
LOD 
(pg/g of 
fat) 
mean range S.D pg WHO-TEQ mean range S.D 
pg WHO-
TEQ mean range S.D 
pg WHO-
TEQ 
2,3,7,8-TetraCDD 0.01 0.11 (22) 0.04-0.51 0.10 0.11 0.13 (12) 0.04-0.35 0.10 0.13 0.32 
(14)
 0.05-1.38 0.39 0.32 
1,2,3,7,8-PentaCDD 0.02 1.54 (2) 0.14-2.89 0.70 1.54 1.81  (1) 0.35-4.31 1.15 1.81 1.17 
(4)
 0.10-3.32 0.83 1.17 
1,2,3,4,7,8-HexaCDD 0.01 0.72 (3) 0.11-3.27 0.71 0.07 0.75 (3) 0.07-2.79 0.72 0.07 0.53 
(6)
 0.07-1.63 0.38 0.05 
1,2,3,6,7,8-HexaCDD 0.01 4.57 0.75-14.10 2.98 0.46 3.90 1.76-10.12 2.19 0.39 3.37  1.50-9.23 1.68 0.33 
1,2,3,7,8,9-HexaCDD 0.01 0.72 (3) 0.09-2.32 0.51 0.07 0.72 (3) 0.20-1.33 0.40 0.07 0.49 
(6)
 0.05-1.53 0.39 0.05 
1,2,3,4,6,7,8-HeptaCDD 0.01 4.23 0.62-16.79 4.42 0.04  3.08 (2) 0.25-6.72 1.87 0.03 3.38 
(2)
 0.08-7.67 2.16 0.03 
OctaCDD 0.01 28.29 5.18-110.83 17.70 0.01 25.99 8.90-41.30 10.09 0.01 23.89 10.46-58.31 11.25 0.01 
2,3,7,8-TetraCDF 0.02 0.20 (16) 0.02-1.24 0.31 0.02 0.55 (8) 0.03-2.69 0.92 0.05 0.24 
(12)
 0.03-0.88 0.25 0.02 
1,2,3,7,8-PentaCDF 0.02 4.46 (7) 0.03-32.00 2.03 0.13 0.89 (5) 0.05-3.24 1.01 0.03 0.16 
(16)
 0.03-0.84 0.20 0.12 
2,3,4,7,8-PentaCDF 0.02 4.81 2.45-8.90 1.64 1.44 5.90 2.16-11.67 2.75 1.77 4.23 1.72-9.94 2.07 1.27 
1,2,3,4,7,8-HexaCDF 0.01 2.94 0.04-8.59 2.30 0.29 2.81 (2) 0.15-7.37 2.43 0.28 1.92 0.73-5.31 1.22 0.19 
1,2,3,6,7,8-HexaCDF 0.01 1.40 0.54-3.47 0.76 0.14 1.29 (2) 0.15-3.78 1.06 0.13 1.92 0.60-6.15 1.31 0.19 
2,3,4,6,7,8-HexaCDF 0.01 0.52 (8) 0.05-1.85 0.55 0.05 0.70 (6) 0.03-3.51 0.99 0.07 1.01 
(4)
 0.04-4.86 1.03 0.10 
1,2,3,7,8,9-HexaCDF 0.01 0.16 (19) 0.03-1.64 0.35 0.02 0.26 (11) 0.04-2.01 0.56 0.03 0.09 
(21)
 0.03-0.23 0.05 0.01 
1,2,3,4,6,7,8-HeptaCDF 0.03 1.37 0.56-5.40 1.36 0.01 1.77 (2) 0.05-4.88 1.37 0.02 3.48 0.40-36.02 7.61 0.03 
1,2,3,4,7,8,9-HeptaCDF 0.03 0.08 0.02-0.25 0.06 0.0008 0.12 (10) 0.03-0.25 0.08 0.0012 0.11 
(21)
 0.03-0.30 0.06 0.0011 
OctaCDF 0.03 0.82 (2) 0.07-3.09 0.66 0.0002 0.87 (2) 0.15-2.01 0.64 0.0003 0.34 
(18)
 0.01-2.63 0.55 0.0001 
              
Classes of dioxins              
Total TetraCDD 0.01 0.13 (17) 0.04-0.51 0.83  0.25 
(9)
 0.08-0.66 0.19  0.40 
(7)
 0.06-1.38 1.08  
Total PentaCDD 0.02 1.66 0.44-2.89 0.38  1.84 0.73-4.31 1.11  1.38 
(1)
  0.16-5.16 2.04  
Total HexaCDD 0.01 6.94 1.88-18.48 0.63  5.82 2.74-15.76 3.48  4.81 1.74-12.14 2.07  
Total HeptaCDD 0.01 4.46 0.62-16.79 0.99  3.28 
(2)
 0.50-6.72 1.84  3.69 0.15-7.67 7.78  
Total TetraCDF 0.02 6.33 (3) 0.07-9.23 1.36  7.84 2.16-28.45 5.79  1.02 
(1)
 0.07-6.49 0.44  
Total PentaCDF 0.02 16.15 4.46-36.10 0.82  16.01 4.13-39.73 11.45  4.32 1.73-10.00 2.26  
Total HexaCDF 0.01 18.71 2.73-85.14 1.14  13.82 0.31-49.27 14.71  4.82 0.07-14.66 1.37  
Total HeptaCDF 0.03 14.19 1.25-74.36 1.27  5.20 
(1)
 0.09-14.12 4.60  5.36 0.16-37.64 3.51  
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Table 18 Concentration of PCDDs/F and PCB congeners and classes of these compounds in human milk collected in Piacenza Milan and Giugliano. In 
parentheses is the number of samples below the limit of detection 
[ng/g of fat]  Piacenza  Milan  Giugliano in Campania  
Dioxin like PCBs 
LOD 
(pg/g of 
fat) 
mean range S.D  mean range S.D  mean range S.D  
PCB-81 0.5 0.02 (17) 0.0002-0.30 0.07  0.08 (4) 0.0005-0.34 0.12  0.003 (10) 0.001-0.007 0.001  
PCB-77 0.5 0.03 (11) 0.0002-0.31 0.08  0.07 (4) 0.0005-0.28 0.09  0.003 (17) 0.0003-0.021 0.004  
PCB-123 0.5 0.16 0.03-0.45 0.13  0.26 0.15-0.73 0.17  0.09 (1) 0.01-0.28 0.06  
PCB-118 0.5 7.95 3.53-22.03 5.25  8.34 4.04-25.04 6.95  7.30 2.03-16.14 3.43  
PCB-114 0.5 0.70 0.17-2.70 0.61  0.64 0.03-2.84 0.80  0.32 0.12-0.78 0.16  
PCB-105 0.5 1.41 (1) 0.0004-4.52 1.03  1.55 0.92-4.54 1.21  1.93 0.42-10.88 2.17  
PCB-126 0.5 0.03 (8) 0.0003-0.09 0.03  0.03 (4) 0.0003-0.14 0.03  0.04 (2) 0.01-0.08 0.02  
PCB 167 0.5 1.18 0.49-2.49 0.64  1.00 0.41-2.40 0.58  1.52 0.39-14.18 2.93  
PCB 156 0.5 4.41 1.91-10.43 2.65  3.51 0.82-13.16 3.62  2.56 1.28-5.68 1.07  
PCB 157 0.5 0.85 0.31-2.05 0.48  0.85 0.24-3.50 0.96  0.51 0.25-1.26 0.23  
PCB 169 0.5 0.06 0.01-0.31 0.08  0.08 0.01-0.04 0.11  0.02 (4) 0.01-0.04 0.01  
PCB-170 0.5 13.91 1.35-39.91 10.65  7.48 1.74-19.18 5.23  7.16 2.18-16.76 3.56  
PCB-189 0.5 0.47 0.10-1.55 0.35  0.32 0.11-0.64 0.18  0.27 0.08-0.77 0.16  
Indicator PCBs              
PCB 28 0.3 1.20 0.04-3.28 0.85  1.58 0.14-9.67 2.89  0.22 (3) 0.001-0.65 0.18  
PCB-52 0.3 0.27 0.08-0.57 0.15  0.28 0.02-0.58 0.17  0.15 (2) 0.001-0.49 0.15  
PCB-101 0.3 0.36 0.15-1.49 0.30  0.45 0.14-0.65 0.15  0.25 0.03-0.93 0.21  
PCB-118 0.3 7.95 3.53-22.03 5.25  8.34 2.43-25.04 6.95  7.27 2.00-16.10 3.43  
PCB-153 0.3 37.82 1.37-94.64 27.02  21.85 1.15-84.02 26.92  33.10 13.39-70.62 12.11  
PCB-138 0.3 20.81 1.34-56.05 14.07  10.72 1.21-44.54 12.87  15.86 0.01-32.40 7.67  
PCB-180 0.3 31.36 5.88-90.70 24.15  14.77 5.23-39.60 10.72  15.57 4.05-39.82 8.56  
              
Classes of PCBs              
Total tri-CBs 0.3 1.31 0.32-3.28 0.77  2.49 0.46-9.67 3.37  0.84 0.02-2.94 0.75  
Total tetra-CBs 0.5 6.10 0.09-15.19 4.46  5.66 0.36-19.94 5.65  5.32 1.94-16.12 3.83  
Total penta-CBs 0.5 14.89 0.64-28.56 7.36  15.77 0.88-50.52 13.48  13.37 0.49-33.11 8.03  
Total hexa-CBs 0.3 83.87 25.42-193.32 52.61  62.82 14.10-207.96 58.54  121.81 22.09-414.38 234.65  
Total hepta-CBs 0.3 53.41 11.48-146.91 35.09  25.67 5.86-62.36 17.92  30.74 9.21-119.11 24.20  
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7. PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELLING AND 
HUMAN BIOMONITORING STUDIES  
 
Physiologically based pharmacokinetic (PBPK) models describe the human body as 
a network of compartments representing organs (e.g., blood, kidney, liver, brain, muscle 
and skin, placenta etc). They are defined by mathematic functions related to biochemical 
and physiological processes: absorption, distribution, metabolism and excretion. A PBPK 
model combines three categories of data: “the system’s data (physiological and anatomical 
properties); drug-specific data (e.g., absorption or metabolic rates); and the model 
structure, which refers to the arrangement of tissues and organs included in the model” 
(Bois et al 2010, Rowland et al 2004). Today PBPK models are commonly used in drugs 
development or risk assessment to predict the fate of substances in humans and the 
internal levels in the target tissues, i.e. where the effects of the substance arise. Recently, 
PBPK models have been introduced to interpret biomonitoring data (e.g., blood or urine 
concentrations) observed in the general human population. This association results in a 
powerful tool for the health risk assessment at individual or population level. Over the last 
decades, a number of researchers have investigated the range of internal doses that occur 
in humans from environmental exposures (Bois et al 1996, Spear and Bois 1994, Clewell 
et al 1999, 2000, 2004).  
PBPK models can be used to estimate internal doses based on known external 
exposure (this process is called forward dosimetry), or can be used to estimate the 
exposure levels in the environment that could give rise to measured biomarker 
concentrations in a population and this process is called reverse dosimetry. (Clewell et al 
1999, Aylward et al 2005, Stern et al 2005). These two approaches are complementary to 
each other and provide different perspectives on the implications of biomonitoring data 
from the perspective of human health risk. In this study, both approaches are used: 
reverse dosimetry to reconstruct the mother dose to PCB-153 and forward dosimetry to 
predict the tissues concentration in mother and the PCB-153 intake of breastfed children. 
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8. LIFETIME WHOLE-BODY PBPK MODEL of MOTHER and INFANT 
 
The development of a PBPK model follows a four-step approach: model representation, 
parameterization, simulation and validation. The PBPK model used in this study was 
described previously (Beaudouin et al 2010), but was modified to integrate refined 
information on the chemistry and physiology of breast milk during lactation. Additionally 
prenatal transfer mother-fetus via placenta was improved thank to application of new 
placenta composition during fetus development, and new partition coefficient placenta: 
blood. 
8.1 Model presentation 
 
The structure of the lifetime model for mother and infant was developed by 
Beaudouin et al (2010). The human body is described as a tissues network and consists of 
22 compartments representing organs (lungs, adipose tissue, adrenals, bones, brain, 
breast, pancreas, spleen, stomach, gut, liver, sexual organs, heart, skin, marrow, muscles, 
thyroid, urinary tract, kidneys). To describe the pregnancy and fetal developments 
(placenta, amniotic fluid and fetus), 19 compartments were added. All compartments 
represent a specifi organ or tissue exept the urinary track and sexual organs 
compartments. The urinary track includes the bladder, the ureters and the urethra. The 
sexual organs compartments for woman includes ovaries the fallopian tubes and the 
uterus. The scheme of the model is presented in Figure 24. All organs are assumed to be 
well mixed and blood-flow limited. Exchanges with the fetus occur via the sexual organs 
compartment. Absorption of PCB 153 was assumed to be 100%. Elimination occurs via 
metabolism, urinary and fecal excretion exhalation and milk production. 
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Figure 23 Scheme of PBPK model (Beaudouin et al 2010) 
 
Absorption 
PCB153 inputs directly to the liver, and absorption in gut was assumed to be 100%. 
Inhalation takes place in arterial compartment via lungs, however in case of persistent 
organic pollutants is the minor exposure pathway. 
 
 
Distribution 
Distribution is managed by blood flow and tissue:blood partition coefficients. Several 
mass balance equations were established to describe the quantity of chemical in each 
compartment  which based on general dependence (Eq. 1): 
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( ) ( ) ( )





−×=
i
i
arti PC
tC
tCF
dt
tdQ
  (Eq. 1) 
where: Q is the quantity of chemical in each compartment, Fi the blood flow entering 
compartment i, Cart – the concentration in arterial blood, Ci the concentrations in the tissue 
i, PCi – the tissue i: blood partition coefficient 
 
Metabolism and Excretion 
 
PCBs are poorly metabolized and elimination of unchanged chemicals was assumed. The 
elimination in liver via biliary excretion is considered as the main excretion route and the 
urinary excretion, in case of PCBs, can be skipped. Metabolism and biliary excretion are 
parameterized from half-life values (for PCB-153: 27.5 years). These processes were 
assumed to depend on age but not on gender. A first order model was defined. The 
intrinsic clearance value per kilogram of liver (CLintC) is given by:  
age
age
ageage Vl
Eh
QlEh
CL
C
/
1int 







−
×
=       (Eq. 2)  Where:   Ehage=CLage/Qlage   (Eq2.1) 
       
( )
ageageageage VbVtPVd +×= ∑  (Eq2.2)
       ( )( ) ageage VdhHLCL ×= /2ln    (Eq2.3) 
And: 
Ql   - the blood flow to the liver,  
Vl   - volume of the liver,  
CL  - clearance for the studied compound,  
Vd  - the volume of distribution, 
P    - tissue:blood partition coefficient, 
Vt   - the volume of tissues 
Vb  - the volume of blood. 
 
 Additionally excretion through the breast milk was managed by milk flow out of 
the mammary tissue compartment and milk:blood partition coefficient.  
 
( )
milk
breast
breast
milk
milk PC
PC
tCF
dt
dQ
××=   (Eq.4) 
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8.2 Parameterization 
 
Quantitative relationships between the tissues volumes, BW and other parameter 
with age were described previously (Beaudouin et al 2010), and included effects of aging 
and athropy on muscles or adipose tissues.  
 
Partition coefficients tissue:blood 
Tissues:blood partition coefficients represent an important set of input parameters 
for PBPK models. They describe the concentration of the substance in a target tissue to its 
concentration in blood under equilibrium conditions. For PCB-153, partition coefficients 
tissue: blood were estimated using Parham’s approach (Parham et al 1997). This 
Quantitative Structure-Activity Relationship (QSAR) has been developed only for PCBs 
and relies on the structural information of the molecules (See Eq.5-8). Several structural 
parameters such as UNS - an indicator of whether the congener has a ring on which 
adjacent meta and para carbons are not chlorine- substituted or NPL - a variable 
describing the nonplanarity of the PCB, were selected as predictors of the affinity of PCBs 
to tissues (see Table 20 for the set of the structural parameters). The first step was to 
estimate, from the structural descriptors, the fat:plasma partition coefficient (PCfp), and 
than to convert it to fat:blood partition coefficient (PCfb).The fat:plasma partition coefficient 
is obtained from: 
Log(PCfp)=1.9988 – 0.5004ˣUNS+0.1793ˣNPL+0.05931ˣDIFF2   (Eq. 5) 
 
The ratio plasma:blood (rpb) is used to convert the fat:plasma partition coefficient into the 
fat:blood partition coefficient: 
PCfb = PCfp ˣ rpb           (Eq. 6) 
rpb = NUNMP
NUNMP
×+
×−
07.024.1
31.065.1
        (Eq. 7) 
( )
NUNMP
NUNMPPC fb
×+
×−
×= ×+×+×
07.024.1
31.065.110
2DIFF0.05931NPL0.1793UNS0.5004 - 1.9988
   (Eq. 8) 
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Parameters Descritption Values  Parameters Descritption Values  
NOC Number of ortho (2, 6, 2*, or 6*) chlorines 2 R1 is 1 if there is a ring with 0 or 1 
chlorines, 0 otherwise 0 
OC  is 1 if NOC >0, 0 otherwise 1 NUNMP Number of adjacent non-chlorine-
substituted meta–para carbon pairs 0 
NPL is NOC if NOC <2,is 2 otherwise 2 UNS is 1 if NUNMP >0, 0 otherwise 0 
NMC Number of meta (3, 5, 3*, or 5*) chlorines 2 UNMP is 1 if NUNMP>1, 0 otherwise 0 
NPC Number of para (4 or 4*) chlorines 2 ACARB Largest number of adjacent  
non-chlorine-substituted carbons 4 
NCL Total number of chlorines 6 AC Largest number of adjacent chlorines 4 
R MAX Number of chlorines on most-substituted 3 ACM   is AC-1 if ACM>0, 0 otherwise 3 
R MIN Number of chlorines on least-substituted 3 NUNMP Number of adjacent non-chlorine-
substituted ortho–meta carbon pairs 0 
DIFF RMAX-RMIN 0    
 
Table 20. Structural parameters for Parham’s approach (Parham et al 1997) 
 
The partition coefficients for tissues other than fat were determined by multiplying 
PCfb with an adjustment factor depending on the lipid content of the tissue. The adjustment 
factor was proposed by Poulin and Krishnan (1995). They considered that the lipophilicity 
– hydrophilicity behaviour of phospholipids might be approximated by the fractional 
additivity of neutral lipids 30% and water 70% solubility characteristics (Poulin Krishnan 
1995, Williams and Tung 1979). The quantity of phospholipids can then be transformed 
into neutral lipids equivalent and water equivalents according to equation below:  
Ltot tissue = FNL + 30% FPL  (Eq. 9a) 
Wtot tissue = FW + 70% FPL  (Eq. 9b) 
AFadj.tissue = Ltot tissue/Ltot adipose (Eq. 10) 
 
Where: 
AFadj.tissue Adjustment Factor for tissue 
Ltot tissue Total lipid content of tissue 
Ltot adipose Total lipid content of adipose tissue 
FNL  Fraction of neutral lipids 
FW  Fraction of water 
FPL  Fraction of phospholipids 
 
Since the composition of tissues changes from childhood to adulthood, the values of the 
partition coefficients tissue:blood may be modified. A literature overview was performed in 
order to extract the most accurate lipids concentration with the special attention putted on 
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young infant tissues. The innovation in this study is the application the Parham approach 
to the tissues in early age after birth.  
Figure 24 presents the lipid content of several tissues and corresponding partition 
coefficients. 
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Figure 24. Fat content and partition coefficient for kidney, muscle and liver tissues 
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Maternal parameter and  model inputs for nursing variables 
 
Maternal parameters were taken from the previously published model (Beaudouin et 
al 2010) with important modification of secretion of milk during lactation. Lactogenesis in a 
limited way appears already during pregnancy. Secretion before delivery is called stage I, 
and copious secretion after delivery - stage II. Initiation of the secretion does not depend 
on suckling by the infant, but its rate declines when milk subtracted is not practiced 
(Wooldridge et al 1985). During stage I, approx. 30 mL of colostrum per day can be 
secreted but as this secretion cannot be removed by suckling, the components are 
reabsorbed into the mother’s blood stream. Stage I of lactogenesis was not then modelled. 
During stage II, the composition of milk and the volume of milk excreted per day evolve. 
Thus several parameter were modified form our previous model (Beaudouin et al 2010). 
Milk excretion from the mother and intake by infant can be expressed as a function of 
infant’s age (Neville et al 1988, Arcus-Arth et al 2005 and Verner et al 2009). Figure 25 
presents the milk yield and infant milk intake during 400 days after delivery (Neville et al 
1988)). We considered a 6 months period of exclusively breastfeeding and partial weaning 
for another 6 months. The evolution of the milk production is in agreement with a decrease 
in milk volume when the infant is weaning or supplementary food is included in his diet.     
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Figure 25. Correlation between infants age (in age) and milk intake during lactation  
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Similar modifications were applied to describe the milk composition during 
lactogenensis (Paul et al 1997, Michaelsen et al 1990,1994,  Guerrini et al 1981, Dewey et 
al 1984, Mitoulas et al 2002, Bitman et al 1984, 1986, 1989, Kent et al 1999, 2006 , 
Underwood et al 1970, Crawford et al 1976, Larnkjaer et al 2006, Mandel et al 2005, 
Woodward et al 1989). The lipids and phospholipids concentrations in milk change during 
lactogenensis, and then may impact the affinity of PCB-153 to milk (partition coefficient 
milk:blood). Information on the milk composition was integrated in our model to describe 
these changes. Figure 26 presents the lipid content during lactation as a function of time 
(days), and the impact on the partition coefficient.  
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Figure 26 Milk fat content and partition coefficient milk: blood in function of time in days 
 
8.3 Bayesian analysis to estimate the exposure and some key parameters 
 
8.3.1 Estimation of key parameters from an independent dataset 
Before using the PBPK model to reconstruct the exposure of the Italian women, we 
compared the model’s predictions to an independent dataset obtained from literature: 
German survey on couples: mother child from 1996 (Abraham et al 1996). This study was 
selected because it contains a complete description of the infants’ exposure and the 
sampling of the different tissues (venous and cord blood, milk, and placenta). This study 
contained also wide range of tissues measurements performed for individuals (couple 
mother child), which is crucial to verify the behavior of the PBPK model.  
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First we parameterized the PBPK model and the exposure model as defined above and 
run the models for the German women. However the predictions were far from the 
concentrations observed in those women (results not shown). We then selected few 
parameters to estimate, for which a high uncertainty affects the estimates from previous 
knowledge (e.g., literature). Four parameters were selected: the diffusion rate between the 
mother’s uterus and the placenta, scaling factors for blood:milk and blood:placenta 
partition coefficients and a scaling factor for the daily intake of PCB-153. We chose to 
estimate scaling factors and not the parameters themselves to keep the time evolution of 
these parameters during the pregnancy, lactation or lifetime. The individual concentration 
of PCB-153 in venous and cord blood, milk, placenta were used to calibrate the model 
 
8.3.2 Reverse dosimetry for the Italian women 
The reverse dosimetry for the Italian women was performed with the PBPK model 
parameterized with the estimated values of the diffusion rate between the mother’s uterus 
and the placenta, and the scaling factors for blood: milk and blood: placenta partition 
coefficients obtained from the analysis of the Abraham’s dataset (Abraham et al 1996). For 
each Italian woman, we estimate the scaling factor for the daily intake of PCB-153 to keep 
its time evolution during the last century.  
 
8.3.3 Bayesian analysis 
The analysis of the German and Italian datasets was performed in a Bayesian framework. 
Non-informative prior distributions for each parameter were defined and are described in 
Table 21. Markov Chain Monte Carlo (MCMC) methods were used to numerically obtain a 
sample of parameter values from their joint posterior distribution. The MCSim software 
was used to perform the analyses. For each dataset, two independent MCMC chains were 
run until convergence was reached 
 
Parameters Prior distribution 
diffusion rate between uterus and placenta Uniform (0, 0.1) 
scaling factor for blood: milk partition coefficient Uniform (0.001, 10) 
scaling factors for blood: placenta partition coefficient Uniform (0.001, 10) 
scaling factor for the daily intake Uniform (0, 100) 
 
Table 21. Prior distributions for the PBPK model parameters to estimate 
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8.4 Results and discussion 
 
8.4.1 Model verification 
 
The PBPK model was fitted to the Abraham data. The parameters estimates are given in 
Table 22. Our results suggest that the partition coefficients for milk and placenta predicted 
with the Parham’s approach are over-estimated (38% for milk and 54% for placenta). The 
estimates are quite precise, since the coefficient of variation is quite low. We also 
observed that the intake for the German population derived from studies on food 
contamination and consumption was too high. Our results conclude that only 5% to 8% 
was necessary to obtain the internal levels observed in these women 
 
Parameters Mean CV (%) Confidence interval 95% 
Diffusion rate between uterus and placenta 0.00027 34 0.000151 – 0.000375 
Scaling factor for milk:blood partition coefficient 0.62 15 0.52 – 0.78 
Scaling factor for placenta:blood partition coefficient 0.46 6 0.40 – 0.51 
Scaling factor for the daily intake    
Mother I 0.0516 6 0.0467 - 0.058 
Mother III 0.0794 7 0.0703 - 0.0919 
Mother IV 0.073 5 0.0656 - 0.0786 
 
Table 22 Parameters’ estimates from Abraham data 
 
The fits of the model are in good agreement with the experimental data (see Figure 27A-D 
for tissue dosimetry correlation for one woman). The decrease in the placenta and cord 
blood concentrations and the increase in milk correspond to the delivery. The decrease in 
milk corresponds to the end of the lactation period. The model was not able to reproduce a 
high decrease in the concentration in the venous blood of the woman. However, 
considering all the results, the verification step allows to consider our PBPK model to 
reconstruct the exposure of Italian women with a single sample in breast milk.  
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Figure 27A milk PCB-153 concentration                  Figure 27 B placenta PCB-153 concentration 
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Figure 27C venous blood PCB-153 concentration   Figure 27 D cord blood PCB-153 concentration 
 
Good close agreement was obtained also for reverse dosimetry, here the special 
attention was putted on the character of the curve representing the history of dietary intake 
during the post ban period. Our model was able to predict the decreasing tendency over 
the lifetime of the German woman (1959-1993). The verification step gave the confidence 
to our model. 
 
8.4.2 Reverse dosimetry 
 
Using our PBPK model, reverse dosimetry simulation was carried out to estimate 
the possible exposure scenarios leading to breast milk contamination with PCB-153 in 
Italian women in 2009. As mentioned before reverse dosimetry was performed with the 
PBPK model parameterized the estimated values of the diffusion rate between the 
mother’s uterus and the placenta, and the scaling factors for milk: blood and placenta: 
blood partition coefficients. For each Italian woman, the scaling factor for the daily intake of 
PCB-153 was estimated to keep its time evolution during the last century (Figure 29B). 
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The estimated values of the scaling factors vary among the women from 0.04 to 40. This 
high variability only reproduces the variability observed in the milk concentrations. 
However three women have PCB-153 levels in the milk that significantly differ from the 
other women. Two of these women are from Piacenza and exhibit very high levels of PCB 
in milk (26.21 and 17.42ng/g fat in milk for women born in 1987), and one form Milano 
exhibit very low levels in milk (1.37 ng/g fat in milk for a woman born in 1972). If these 
three women are excluded, the scaling factors are estimated between 0.1 and 11 (thus 
reducing the variability by a factor 10). Table 23 presents the average scaling factor 
according to the age of the women. We clearly observed that, the predicted intake for 
women born in the 70’s is close to the initial intake predicted from food studies (See 
chapter 4.2) (the minimum intake). However for women born in the 80’s, the initial intake is 
too low since the scaling factors are around 7. It means that a higher exposure to PCB-153 
is needed to reach the levels in milk.  
Year of birth Average scaling factor Year of birth Average scaling factor 
1971 1.6 1982 7.3 
1972 1.3 1983 6 
1973 1 1984 8.9 
1974 1.7 1985 8.2 
1975 1.1 1986 5.7 
1976 1.5 1987 8.1 
1977 2.2   
Table 23 Average scaling factor according to the age of the women. 
 
Results of the dose reconstruction are presented in the Figures 29 A-B. Model was 
able to reflect the decreasing tendency of daily intake, what can be noticed in the 
reconstruction of the dose for mothers born in 1971-74 (See Figure 29A). The 
characteristic shape of curve representing intake is a results of the changing food 
contamination during mother’s life and changing dietary habits. Strong decrease around 
1980-1982 reflects the ban of PCBs production. This profile can be still noticed in intake of 
woman born in 1976-1978, however disappears in group of women born in 1982-1987. 
Intake predicted for the youngest woman slopes gently and reflects diminished 
contamination of the food. It is important to notice that during this period several EU 
directive were set in order to reduce the introduction of POPs (i.e. PCBs) to environment 
(European Directives on the reduction of the emission limits of PCDDs/Fs and PCBs from 
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waste incineration set by EU Directive 2000/76/EC, or Commission Regulations such as 
(EC) No 466/2001 and 1881/2006 setting maximum levels for certain contaminants in 
foodstuffs) and effectively diminished human exposure to contaminants. For each Italian 
woman, was estimated also the scaling factor for the daily intake of PCB-153 to keep its 
time evolution during the last century. Scaling factors represent the variability of the 
population. 
Predicted intake can be compared with the assessment studies prepared for Italian 
population and focused on the exposure to non-dioxin-like PCBs. (Baldassarri et al 1995, 
Zuccato et al 1999, Fattore et al 2008). Assessment study conducted in the late eighties 
and early nineties (Badassarri et al 1995) indicated the daily intake ca 2000 ng/day based 
on food measurements. Similar study in the middle of nineties noted strong decrease and 
estimated the daily intake 370±300 ng/day (Zuccato et al 1999). Model prediction of the 
intake for this period is in a good agreement with study of Zuccato, however lower of one 
order of magnitude compared with study of Baldassari. In the most recent study of Fattore 
et al (2008) authors estimated the daily intake of total NDL-PCBs 11.5 ng/day/kg b.w for 
population aged 0.5-95 years for the beginning of 2000. The body weight used to calculate 
this value is not known. The average intake of one PCB-153 predicted by model for these 
years was 0.6 ng/day /kg b.w (for adult woman of 60 kg after delivery). In this comparison, 
it seems that PCB-153 account for ca 5% of total NDL-PCB intake, this result seems to be 
slightly underestimated.  
To explain these underestimations several reasons may be suggested: first that the real 
dietary intake of PCBs in Italian population in the late eighties and early nineties was lower 
and the individual effective dose of PCBs was far from estimates calculated for average 
population in study of Baldassarri (1995). The fact is that studies from 1995 did not provide 
any range, neither standard deviation for intake calculation. Second possibility might be 
that the estimation of Fattore is burdened with some uncertainty due to the methodology 
utilised in the study (i.e. body weight), the third explanation might be that PBPK model 
underestimated the population intake. However there is a fundamental difference between 
methodology used in reproduced investigations and methodology used in this work: PBPK 
model bases on physiology and anatomy of human body to calculate the dose which gives 
a target effect in the tissue, while the calculatio
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combination of consumption rate and food contamination. Therefore in order to obtain the 
individual intake, a PBPK model needs to be used.  
Beside this, reverse dosimetry results were confirmed by prediction of PCB milk 
contamination. Very close agreement with measurement data was obtained. Figure 29 
below presents the predicted and measured concentration of PCB-153 in breast milk. A 
mean ratio measurement / prediction was 1.06±0.17 (median 1.04, range 0.80-1.84). This 
clearly shows accuracy and precision of the PBPK model predictions, and gives 
confidence in the PBPK model used in this study.  
  
 
0
20
40
60
80
100
120
0 20 40 60 80 100 120
C
o
n
ce
n
tr
a
ti
o
n
 i
n
 m
il
k
 p
re
d
ic
te
d
Concentration in milk observed
 
Figure 28. Predicted and measured concentration of PCB-153 in breast milk 
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Results of reverse dosimetry 
simulation.  
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8.4.3 Forward dosimetry 
 
PBPK model simulation of PCB-153 content in blood 
 
In order to test the sensitivity and accuracy of model prediction in mean of forward 
dosimetry the mother blood was chosen. As mentioned in the beginning PCBs are 
recognized as endocrine disruptors which may alter hormonal balance, therefore the 
knowledge of their levels in blood is an important issue. Several studies showed the 
correlation of endometriosis with higher exposure of PCB (Koninckx et al 1994, De Filip et 
al 2004, Van Larebeke et al 2001, Gerhard and Runnebaum, 1992; Heilier et al., 2004; 
Buck Louis et al., 2005, Pauwels et al 2001). An association between PCBs 138, 153 and 
180 and endometriosis had been observed in a study carried out in German women 
(Gerhard and Runnebaum, 1992); similar results were obtained by Heilier et al 2004. 
Blood concentrations for woman born between 1971 and 1986 generated by model 
were within the literature ranges. As presented in the Figure 30, there are notable 
differences in blood levels between older and younger mothers over their lifetime. The 
model predicted the blood concentration in mothers born in 70ies higher than in mothers 
born in mid 80ies, what reflects different environmental exposure. Predicted results are in 
good agreement with literature. For example Todaka et al 2010 found PCB-153 at level of 
26.82±15.4 (range 9.25-120) in 30 years old mother (sampling in 2002), prediction of 
PBPK model for woman born in 1971-1974 was in range 28-60 ng/g of lipid blood. Another 
example of accuracy of model prediction is a good agreement with recent Italian study of 
Porpora et al (2006), where in blood of young Italian woman with and without 
endometriosis was examinated for concentration of PCBs Indicators. In blood of 29 year 
healthy nulliparous PCB-153 was found at concentration 95 ng/g lipid blood (SD=55). 
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Figure 30. Prediction of mother blood concentration from birth until delivery 
 
In fragmentary enlargement (upper zoom in Figure 31) can be easily noticed the 
characteristic decrease in blood concentration (around 2009) in all profiles predicted by 
PBPK model. It is known that delivery and breastfeeding reduce PCB levels in mother. 
Decrease in PCB blood concentration appears during pregnancy and lactation due to the 
presence of a foetus and production of milk, what rapidly changes the body burden.  
In order to investigate the influence of pregnancy and lactation on kinetic of PCB-153 in 
blood additional simulations were performed.  
Figure 31 below presents results of simulation for three different scenarios. First scenario 
was performed for woman without pregnancy and without lactation, in order to see the 
basic level of blood contamination (red line). The second scenario assumed the pregnancy 
at 23 years followed by 6 months breast feeding (blue line). The third scenario assumed 
the pregnancy alone (green line). 
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Figure 31. Kinetic profiles for PCB-153 in blood concentration  
 
Simulations show that the pregnancy alone induces a drop in the blood 
concentration that rapidly returned to pre-pregnancy levels, suggesting that the observed 
decrease is due to the modification of the physiology of the woman (increased volume of 
fat, blood and breasts) rather than a significant transfer to the foetus. Simulation for 
pregnancy followed by breastfeeding showed that lactation has a greater impact on the 
blood concentration. In fact the excretion of milk is an important route of POPs elimination 
and exerts major change in kinetic profile.  
 
PBPK model simulation of infant exposure to PCB-153  
 
PBPK model was used to predict the infant exposure to PCB-153. The period breast 
feeding was set for 9 months, where 6 of full breastfeeding, and 3 of partial feeding. The 
milk concentrations were set individually for each mother based on measurement from 
human breast milk monitoring. The volume of milk ingested was modelled with the same 
equation used for the milk excretion. Model predicted the daily intake for each infant 
[ng/day/kg b.w.], and results are presented in Figure 32 below.  
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Figure 32. Infant exposure to PCB-153 via breast milk: daily intake and cumulative intake.  
 
The shape of intake curves is determined directly by different breastfeeding periods: 
6 months exclusively breast feeding, 3 months of partial weaning. Notable difference can 
be observed between intake of baby born to younger and older mother, what is a 
consequence of longer exposition to contaminants. Upper graph shows the cumulative 
intake after all breastfeeding period.  
 
8.5  Conclusions 
 
This study attempted to interpret the human biomonitoring study in mean of mother 
and infant exposure characterisation. The model used in this study was a stochastic whole 
body life-time PBPK model based on detailed description of the human physiology and 
anatomy (Beaudouin et al 2010) and was examined to predict historical exposure that is 
associated with specific biomarker in breast milk. Based on measurement data derived 
from breast milk monitoring conducted recently in Italy, the reverse and forward dosimetry 
were performed. PBPK modelling was shown to be a relevant method to assess an infant 
postnatal exposure to PCB-153, to reconstruct the historical exposure of mother during her 
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life time, and to predict PCB-153 blood concentration from mother’s birth until first delivery. 
This study is the first to propose the reconstruction of life-time intake by PBPK model 
based on single breast milk measurement.  
Reconstruction of dietary intake trend over the mother’s life was performed in mean of 
reverse dosimetry thank to several improvements applied to existing PBPK model. Among 
the modification important were: new data about the tissues composition and new partition 
coefficients tissue: blood calculated for young organism (PC placenta: blood, PC milk: 
blood). Crucial for this study was the parameterisation of several parameters like the 
diffusion rate between the mother’s uterus and the placenta, milk: blood and placenta: 
blood partition coefficients, which greatly improved a prenatal and postnatal transfer 
between mother and infant. Moreover the estimation of scaling factor for the daily intake of 
PCB-153 resulted in accurate reconstruction of intake evolution during the last century and 
give important information about variability of the population.  
It is well known that breast milk is good predictor of an infant exposure, and several 
studies showed how to use the PBPK model for infant exposure assessment. (Clewell et al 
2002, 2008). Only a few articles dealt with mother exposure reconstruction based on 
breast milk studies. (Lorber and Phillips 2002, Alyward et al 2005), investigations 
considering PCBs are even less (Redding et al 2008, Verner et al 2009). In all these 
studies it was assumed that mother exposure is constant. However this assumption is not 
correct, especially when modelling is performed for POPs such as PCDD/Fs , PCB or 
DDT. It is well known that occurrence of these compounds is characterized by a 
decreasing trend. Such a trend appears after use and production of a chemical that has 
been restricted or banned. This is exactly the case of PCBs, which were being produced 
intensively in mid 70, and than have been banned. Often such an environmental 
distribution in time takes the form of bell-curve. Simple decreasing trend is fitted with 
exponential function (log-linear regression).  
 An understanding of past exposure is important to place current body burdens in 
perspective, and also useful in assessing potential future exposure. Very few direct 
measurements of the main sources of exposure to PCBs (i.e., soil, food) over the past 
decades are available. Especially the lack of data in food measurement in the past induces 
a need to develop new methods to reconstruct realistic scenarios of human exposure or 
human intake. Moreover, very important is to create a scenario that accurately reflects the 
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situation for specific population, geographic regions or country. Combination of breast milk 
monitoring with PBPK model allowed to model a dynamic exposure to reflect the evolution 
of environmental levels of PCBs in Italy.  
Simulations included also the prediction of mother blood concentration of PCB-153. PCBs 
are recognized as endocrine disruptors which may alter hormonal balance. Therefore the 
knowledge of their levels in blood is an important issue. Several investigations showed the 
correlations between higher level of PCBs indicators in blood and endometriosis (Buck-
Luis et al 2005, Koninckx et al 1994, De Filip et al 2004, Van Larebeke et al 2001, Gerhard 
and Runnebaum, 1992). Also in this case model estimated realistically the history of 
mother blood concentration, proving its sensitivity and accuracy.  
The modelling outcomes provided an historical perspective on the changing 
exposure of the Italian population to PCB-153. It was proved also that breast milk is good 
biomarker of historical exposure and in combination with PBPK modelling can be used to 
reconstruct the mother dose. So far, this is the first study which reconstructed the dynamic 
exposure for specific population. Results of this work can dramatically change the way to 
perform modelling for substances such us POPs, as similar trends to PCBs is observed for 
PCDD/Fs, DDT, HCB etc. Challenging may be modelling for substances such as PBDE 
which are characterized by increased tendency, and their amount in environment grows 
up. 
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10 ANNEX 1 
Questionnaire for human milk donors 
      
 
      
QUESTIONARIO DI SCREENING 
 
 
1- Hai programmato di allattare al seno tuo figlio?                                  SI    
NO 
 
2- E’ il tuo primo figlio?      SI     
NO 
 
3- Stai aspettando un solo bambino? (no indica gemelli)                        SI     
NO 
 
4- Stai avendo una gravidanza senza problemi di salute?                        SI     
NO 
    Se no, quali: 
 
5- Risiedi nella stessa zona da almeno 10 anni?                                      SI     
NO 
    Se no, da quanti anni? 
 
6- Hai meno di 30 anni?                                                                           SI     
NO 
 
7- Risiedi nelle vicinanze di aree di discarica, aree industriali,  
    strade ad intenso traffico, zone di incendi di rifiuti all’aria aperta?     SI     
NO 
    In caso di risposta affermativa precisare le distanze dall’abitazione: 
- area di discarica: 
- area industriale: 
- strada ad intenso traffico: 
- zona di incendi di rifiuti all’ aria aperta: 
 
8- Qual è la tua attuale condizione lavorativa? 
 
9- Durante lo svolgimento del tuo lavoro sei stata mai esposta ad  
    agenti chimici o fisici?  SI     
NO 
    Se si, quali? 
 
10- Abitudine al fumo:  SI     
NO 
      Se si, indicare il numero di sigarette al giorno: 
ANAMNESI PATOLOGICA 
 
 
 
Patologie diagnosticate in passato: 
 
 
 
 
 
 
 
 
      
 
 
        
 
 
 
Patologie in atto: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CODICE 
IDENTIFICAZIONE  
INDIVIDUALE 
CODICE IDENTIFICAZIONE DEL 
POOL 
 
 
 
 
 
 
INFORMAZIONI PERSONALI 
 
 
 
Nome:                                        Cognome: 
 
Data e luogo di nascita: 
 
Indirizzo: 
 
Telefono: 
 
e- mail:                                              @ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          “PROGETTO NUOVA VITA” 
                      Studio epidemiologico sui livelli di diossina   
                      nel latte materno 
 
 
REGIONE LOMBARDIA 
 
 
ISTITUTO “MARIO NEGRI” MILANO 
Dipartimento Ambiente e Salute 
Dott. Roberto Fanelli 
 
 
 
 
STUDIO SUI LIVELLI DI ACCUMULO DI 
DIOSSINE NEL LATTE MATERNO QUALI 
INDICATORI DI INQUINAMENTO 
AMBIENTALE NELLA CITTA’ DI MILANO 
 
 
 
 
 
 
 
Data: 
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ABITUDINI ALIMENTARI 
 
 
Come descriveresti le tue abitudini alimentari prima della gravidanza? 
  Dieta mista                                          Vegetariana ma con latte e uova 
  Strettamente vegetariana                     Altro 
 
 
Quanto spesso hai mangiato i seguenti cibi prima della gravidanza? 
 
      
 
        
chiave e non può essere rivelato a nessuno. I risultati non includono il nome ma 
un codice, inoltre solo la media dei risultati di tutti i partecipanti allo studio sarà 
riportata e non il singolo risultato. Fino a quando il suo campione non sarà unito 
al pool con gli altri, può in qualsiasi momento rinunciare a partecipare allo 
studio. 
Per domande ed informazioni può contattare le seguenti persone: 
 
Dott.ssa Marynka M. Ulaszewska maria.ulaszewska@unicatt.it 339 381 95 37 
Istituto di Ricerche Farmacologiche "Mario Negri" Milano 
Dipartimento: Ambiente e Salute  
Laboratorio: Tossicologia della Nutrizione  
 
 
Ho letto, o mi sono state lette, le predette informazioni. Ho avuto 
l’opportunità di fare domande ed ho avuto risposte che mi hanno 
soddisfatta. Acconsento volontariamente a partecipare allo studio e sono a 
conoscenza che ho il diritto a ritirarmi dallo stesso fino al momento in cui il 
mio campione sarà messo nel pool con gli altri. Se scelgo di ritirarmi dallo 
studio so che in nessun modo ciò comprometterà le mie cure mediche. 
Acconsento affinché ogni eccesso di campione di latte materno possa essere 
utilizzato per futuri studi correlati. 
 
Nome della madre partecipante                             Data e firma della partecipante 
 
 
 
 
 
 
Nome del Sanitario                                                 Data e firma del Sanitario 
 
 
 
 
 
 
 
 
 
MODULO PER IL CONSENSO INFORMATO 
 
Certificato di consenso 
 
Sono stata invitata a partecipare al Progetto “Nuova Vita” da….- Studio 
sui livelli di accumulo nel latte materno di diossine quali indicatori di 
inquinamento ambientale nella regione Lombardia. 
Sono stata informata degli scopi e delle procedure di questo studio, che 
di seguito si esplicitano in breve: 
 
Obiettivi 
Le diossine e le diossine derivate sono un gruppo di sostanze chimiche 
prodotte dall’ uomo che possono essere ritrovate nell’ ambiente che ci 
circonda. Queste sostanze sono abbastanza stabili nel tempo e possono 
essere ritrovate in cibi contenenti grasso, incluso il latte umano. 
Il progetto ha come obiettivo principale la rilevazione dei livelli di accumulo 
delle diossine e delle diossine correlate nel latte materno delle donne 
gravide. Tutte le conoscenze scientifiche continuano a evidenziare i vantaggi 
per la salute dell’allattamento al seno, soprattutto nei primi sei mesi di vita. 
 
Procedure 
Vi viene chiesto un campione di 60-100 mL di latte che sarà prelevato sia in 
maniera naturale che con un tiralatte, sarebbe  meglio  pero’ minimizzare 
il contatto  con  la  plastica. Il campione può essere prelevato sia in ospedale 
sia presso la sua abitazione e sarete adeguatamente istruite allo scopo. Lo 
stesso sarà analizzato per la ricerca delle diossine insieme a quello di altre 50 
mamme ed i risultati potranno essere confrontati con quelli di altri studi per 
una valutazione regionale. Il campione deve essere sempre conservato in 
freezer! Qualora non fosse possibile prelevare 60 ml in una sola volta, si 
possono effettuare diversi prelievi nello stesso vasetto nell'arco di qualche 
giorno,  avendo cura di conservare sempre il latte in freezer. 
Sarà anche distribuito un questionario ad intervista per valutare residenza, 
condizioni ambientali, abitudini, stato di salute dieta ed eventuali esposizioni 
a sostanze tossiche o dannose. 
 
Riservatezza 
Le informazioni raccolte durante questo progetto di ricerca saranno 
strettamente riservate. Esse saranno anonime e contrassegnate da un numero 
cui è associato ogni nome. Il nome associato con il numero assegnato è 
segreto e tenuto sotto  
DA COMPLETARE A CURA DEL COORDINATORE PER 
L’INTERVISTA PRE-NATALE 
 
 
Nome della madre: 
 
Numero di telefono: 
 
Data del parto: 
 
E-mail:                               @ 
 
Indirizzo: 
 
Stato della donatrice in riferimento allo studio: 
  Selezionata                              Riserva 
 
Codice d’identificazione individuale: 
 
 
INFORMAZIONI DA RACCOGLIERSI AL MOMENTO 
DEL PRELIEVO DEL CAMPIONE 
 
Sei intenzionata a firmare il modello di consenso informato?         SI       NO 
Se si, firma il modello di consenso. 
Se no, la madre non è eleggibile per partecipare allo studio. 
 
I neonati devono avere più di tre settimane (21 giorni). 
Il coordinatore deve avvisare la madre di ritornare quando il piccolo ha 
raggiunto le tre settimane per il prelievo del campione di latte. 
Il campione deve essere prelevato dalle tre alle otto settimane dal parto. 
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11. ANNEX 2  
 
Questionnaire WHO Fourth WHO-Coordinated Survey of Human Milk for Persistent 
Organic Pollutants in Cooperation with UNEP 
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*Note that if the answers to questions 5 or 6 was "no", ask what the participant's actual residence 
time and/or birth date. 
If any answers to questions 1-6 were "no" or if the answer to question 7 was "yes", the 
participant is not eligible for this survey.  
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